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DETERMINANTS OF DOPPLER FLOW VELOCITY WAVEFORMS IN 
THE UTEROPLACENTAL AND UMBILICAL ARTERIES
SUMMARY
Non-invasive assessment of blood flow in the 
uteroplacental and umbilical arteries using Doppler 
velocimetry is a promising technique for the identification 
of fetal compromise and seems likely to be introduced widely 
into clinical practice. Nevertheless, many problems remain 
to be resolved regarding the potential use of Doppler in 
obstetrics. These problems arise in part from a lack of 
understanding of which indices are most appropriate for 
describing waveforms and of the factors determining abnormal 
waveforms.
In a cross sectional study of 356 normal and complicated 
pregnancies the three most commonly used indices, the 
pulsatility index, resistance index and systolic/diastolic 
ratio were found to be highly correlated with each other and 
could be used interchangeably unless absence of end 
diastolic velocities was observed. The association between 
advancing gestational age and umbilical artery waveform 
indices, showing reduced placental vascular resistance, was 
confirmed although no such association was seen in 
uteroplacental patterns.
Placental vascular pathology has been implicated in the 
production of abnormal uteroplacental and umbilical artery 
Doppler waveforms. It has been postulated that Doppler 
studies in mid-trimester might identify pregnancies at risk 
of later complications. Elevated maternal serum
15
alphafetoprotein (AFP) in pregnancies with normally formed 
fetuses is also known to be associated with a high risk of 
perinatal complications and a placental pathology has 
recently been suggested as underlying this. To determine if 
Doppler might identify such a lesion, 40 patients with 
unexplained elevation of maternal serum AFP underwent 
Doppler studies in the mid trimester. Although there was a 
significant difference in the incidence of later 
complications from a matched group of control patients there 
was no difference from controls in Doppler indices from the 
uteroplacental or umbilical circulations. Consequently the 
hypothesis that Doppler might identify a placental lesion 
associated with later complications is rejected. 
Furthermore, despite a 40% incidence of complications in the 
elevated AFP group the values obtained were within 
previously published normal ranges for the gestation of 
study and the findings do not support a role for Doppler in 
screening in mid trimester for later complications.
Abnormal waveforms have been reported in pregnancies in 
which the fetus is small-for-dates and in those complicated 
by hypertension but few controlled studies have been 
performed to determine the role played by these conditions 
in producing changes in waveform indices.
A controlled study was performed to determine if 
uteroplacental and umbilical artery waveforms are altered in 
pregnancies in which the fetus is small-for-dates. Waveforms 
were obtained in 32 such pregnancies. No difference in 
uteroplacental waveform indices was identified. In contrast, 
the indices from the umbilical artery were significantly
16
higher, though not necessarily abnormal, compared with 
matched controls. These data suggest that haemodynamic 
changes occur in such fetuses even when, as determined by 
Doppler, uteroplacental perfusion is maintained.
It is known that in some small-for-dates fetuses blood 
viscosity is increased. From Pouseille's equation it is 
known that blood flow is dependent on blood viscosity and 
the need for intra-uterine intravascular transfusion in some 
cases of rhesus disease provided the opportunity to 
determine if an increase in blood viscosity following 
transfusion is associated with an increase in Doppler 
indices of resistance. Twenty women underwent a total of 35 
percutaneous umbilical blood sampling procedures and on 22 
occasions intra-vascular transfusion was indicated from the 
results obtained. The systolic/diastolic ratio was measured 
immediately before and 1 hour after sampling or, if 
performed, transfusion. A reduction in the 
systolic/diastolic ratio was seen whether transfusion was 
performed or not indicating that a reduction in resistance 
to blood flow occurred. This surprising finding suggests 
that umbilical cord puncture itself may result in the 
release of vasodilator substances and this must be 
investigated in further studies.
To determine if pregnancy induced hypertension (PIH) and 
absolute levels of blood pressure influenced waveforms, a 
group of 48 untreated carefully defined patients were 
compared with an individually matched control group. In the 
hypertensive patients the Doppler indices of vascular 
resistance in the uteroplacental vessels were significantly
17
higher than controls. In contrast, the results from the 
umbilical artery analysis showed increased resistance, 
reflected in higher values for waveform indices, only when 
significant proteinuria was present. There was no 
relationship in either circulation between absolute levels 
of blood pressure and waveform indices.
Since Doppler is likely to be employed to assess fetal 
well being in hypertensive pregnancies knowledge of the 
effects of antihypertensive agents on Doppler waveform 
indices is important for interpretation of any changes seen. 
Furthermore, Doppler methods provide the first repeatable 
non-invasive method of assessing the effects of vasoactive 
drugs on uteroplacental and fetoplacental perfusion.
To determine if beta blockade with atenolol given for 
PIH influenced waveforms, ten patients were studied 
immediately before treatment and after treatment was 
established for 6 or 7 days. Doppler indices in both 
uteroplacental and umbilical arteries were unaltered from 
pre-treatment values and were not different from a matched 
group of untreated cases.
To determine if acute reductions in blood pressure, as 
occasionally required in severe PIH, influenced waveforms, a 
group of 9 women with severe PIH were studied following the 
oral administration of nifedipine, a calcium channel 
blocker. Despite significant and rapid reductions in blood 
pressure, no effect was seen on Doppler waveforms in either 
of the circulations studied.
These data suggest that these antihypertensive agents do 
not influence Doppler waveforms and that uteroplacental and
18
fetoplacental perfusion is unaltered following treatment.
In conclusion, uteroplacental waveforms are altered in 
pregnancies complicated by PIH but not in those in which the 
fetus is small-for-dates. Therapy for PIH appeared not to 
influence uteroplacental waveforms. The association between 
elevated AFP levels and later adverse perinatal outcome was 
confirmed but not associated with alterations in 
uteroplacental waveforms.
Umbilical artery waveforms were altered in proteinuric 
PIH and in pregnancies in which the fetus is small-for-dates 
suggesting that a redistribution of cardiac output occurs.
Treatment with atenolol or nifedipine did not influence 
waveforms. Similarly, elevated maternal AFP levels were not 
associated with changes in umbilical waveform indices.
Surprisingly, an increase in haematocrit occuring after 
intravascular fetal transfusion was associated with a 
reduction in waveform indices. This probably results from 
the production or release of local vasoactive agents 
following percutaneous umbilical blood sampling.
Finally, the determinants of Doppler waveforms in 
uteroplacental and umbilical vessels have been studied in a 
controlled fashion and this information should place the 
clinical application of the technique on a firmer 
foundation.
19
Chapter 1 Introduction
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Chapter 1 
Introduction
Chapter 1.1 A brief historical perspective.
The observation that the perceived frequency of a wave 
source moving towards an observer depended on the velocity 
of the source was first predicted on theoretical grounds in 
1843 by Christian Johan Doppler (1803-1857), Professor of 
Experimental Physics at the Imperial University in Vienna. 
Doppler's theory was postulated to explain the changes in 
wavelength of light from double stars and experimental proof 
for the effect which now carries his name was obtained by 
Buys Ballot. This enterprising Dutchman used the newly 
completed Amsterdam to Utrecht railway line to demonstrate 
that the pitch of a horn played by a traveller on a moving 
railway carriage was perceived by a stationary observer to 
increase as the train approached.
The change in pitch became greater as the angle between 
the railway track and the observer's line of sight of the 
train became more acute. The use of horn players may have 
been a factor in determining the publication of this 
observation in a journal of musical appreciation 
(Buys-Ballot 1845).
Shortly after this the development of ultrasound 
began with the discovery by the Nobel laureate, PJ Curie, of 
the piezo-electric properties of certain materials. These 
materials resonate when subjected to a voltage and Curie's 
pupil Langevin, used this property of certain ceramics to 
produce ultrasound which had its first practical application
21
in the detection of submarines during the First World War. 
The Austrian brothers Dussik first used ultrasound to aid 
diagnosis when they attempted to visualise intracranial 
structures using a transmission technigue (Dussik 1942) but 
their work was interrupted by the Second World War and was, 
in any case, flawed by a number of technical and 
methodological problems. However, the rapid advances made in 
the first world war were repeated in the second war as a 
result of renewed military interest. Both ASDIC 
(anti-submarine detection) and RADAR (Radio Detection and 
Range) advanced rapidly and much of the eguipment and 
principles developed at this time became available for peace 
time use. On the completion of hostilities, Wild and Reid 
using ex-US navy eguipment were the first to obtain 2 
dimensional ultrasound images although Howry and co-workers, 
using the disused gun turret of an air force bomber, were 
the first to obtain images of diagnostic value (Hill 1973).
The possibility of combining the Doppler effect with 
ultrasound to identify moving structures was being 
investigated by Satomura (1957) who recorded heart action 
with a continuous wave system. Advances in technology over 
the next four years made Doppler analysis of backscattered 
ultrasound for velocimetry possible. In the meantime, the 
application of ultrasound to obstetrics was being 
established by Ian Donald and his colleagues in Glasgow who 
produced the first contact B mode scanner. Synchronously 
Callagan, Rowland & Goldman (1964) and Johnson et al (1965) 
were working in the US to develop the ultrasonic flow meter 
to detect fetal heart action.
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Johnson's group even identified different flow patterns from 
a variety of fetal and maternal vessels which they could not 
at that time visualise. Bishop (1966) was the first to 
suggest, however, that Doppler ultrasound could be used to 
study fetal and maternal vasculature in continuing 
pregnancies.
Before these developments study of the cardiovascular 
physiology of the human fetus had been limited by its 
relative inaccessibility and indeed it was only in 1822 that 
the first recorded mention was made by the Breton physician, 
Baron Jacques Alexandre Le Jumeau de Kergaradec, of the 
auscultation of the human heart in utero as a method of 
assessing fetal well being. Auscultation of the fetal heart 
may have been accomplished earlier (Pinkerton 1969) but it 
was with 'prophetic foresight' that Kergaradec, quoted 
by Pinkerton (1976), asked "from the variations that have 
arisen in the ...beats of the fetal heart will it not be 
possible to judge the state of health or disease of the 
fetus?"
It was exactly the issue of variations of the fetal 
heart rate that was addressed by Hon (1960) who, using scalp 
electrodes to measure the fetal electrocardiograph, 
identified changes in the fetal heart rate during labour 
which were associated with fetal hypoxia. Abnormal fetal 
heart rate reactivity may now be determined using 
developments of the Doppler apparatus described by Johnson 
and Callagan and fetal cardiotocography is currently the 
mainstay of antepartum assessment.
Nevertheless knowledge of heart rate patterns alone
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provides only a relatively crude assessment of fetal 
cardiovascular physiology. More sophisticated evaluation 
required invasive measurements on fetuses undergoing 
termination of pregnancy by hysterotomy. Most of this work, 
done by Assali, Rauramo & Peltonen (1960) produced reliable 
and reproducible results but the required techniques were 
obviously not applicable to the study of ongoing 
pregnancies.
Almost twenty years later, FitzGerald and Drumm (1977) 
in Dublin, and McCallum et al (1978) in the United States, 
developed a Doppler system to obtain flow velocity waveforms 
from the fetal circulation. The former group, who studied 
patterns from the umbilical artery from 12 weeks to term 
suggested that this new technique of Doppler velocimetry may 
be of value in evaluating conditions like pre-eclampsia and 
intra-uterine growth retardation (IUGR). Since the first 
reports were made there has been an expansion in the use of 
Doppler velocimetry of the fetal vasculature and an
associated improvement in technology which has permitted the 
study of the fetal aorta and cerebral vasculature as well as 
the fetoplacental circulation.
Early attempts to study the uteroplacental circulation 
were also hampered by the invasive nature of the
radio-isotopic studies required to obtain blood flow values 
based on clearance rates from the chorio-decidual and 
myometrial components of this circulation. The first 
application of Doppler velocimetry to the study of the 
maternal supply to the fetus was made by Campbell et al in
1983 and a number of groups have used Doppler to study
24
pregnancies complicated by hypertension and IUGR.
Nevertheless, while there is much enthusiasm for this 
new technique both the role of Doppler in obstetrics and the 
underlying physiology and pathophysiology remain 
incompletely understood. The general aim of the studies 
presented in this thesis is to identify some of the 
determinants of Doppler flow velocity waveforms in the 
uteroplacental and fetoplacental circulations in order to 
place the clinical application of this promising technique 
on a sound scientific base.
Chapter 1.2 Physics of Doppler ultrasound in obstetrics.
The use of measurement of Doppler shift frequency in the 
evalutaion of blood flow relies on the reflection of a 
transmitted ultrasound beam back from the moving column of 
blood in the vessel being studied, to the receiver, both 
transmitter and receiver being housed in the same 
transducer.
More specifically, the Doppler principle states that the 
difference between transmitted and received frequencies is 
inversely related to c, the velocity of sound in the 
insonated tissue (in human tissues 1540m/s), and directly 
related to the transmitted frequency, the velocity of the 
reflecting blood cells, and to the cosine of the angle 
subtended by the ultrasound beam and the propagating 
velocity of the blood vessel being studied (Figure 1.1).
The Doppler shift frequency obtained using modern 
equipment represents the processed signal from the vessel
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under study. Different shift frequencies will be received by 
the transducer which represent different velocities of blood 
cells within the vessel, since blood velocity will not be 
uniform accross the vessel. The technique of Fast Fourier 
Transform (FFT) allows amplitude of the different shift 
frequencies to be measured. The amplitude of any given 
frequency shift is proportional to the number of reflectors, 
ie. blood cells, travelling at that velocity. This is 
usually represented on a grey scale or colour image with
greater amplitude being represented by darker shades. This
method of analysis permits easier vessel identification. FFT 
is now available on all modern Doppler equipment (Burns 
1987) of which there are 2 types, pulsed and continuous 
wave.
a) Pulsed Doppler
All pulsed Doppler apparatus consists of a conventional
imaging transducer and screen and a Doppler system. The
transmitting and receiving functions are performed by 
the same transducer. An interrupted, or pulsed, beam of 
ultrasound is generated and echoes constantly received from 
varying depths which correspond to the time delay between 
signal production and the echo being received. This time 
delay can be used to produce the so-called "gating" 
mechanism whereby vessels at a predetermined depth can be 
studied by only analysing signals returning after a certain 
time delay and consequently from a known depth. Signals 
returning after the selected time delay represent changes in 
vessels deeper than the one being studied and these 
frequency shifts are also excluded in order to produce a
26
discreet signal from the desired vessel. Signals received 
early, before the "gate" is opened, are also rejected. As 
can be seen from equation 1 (Figure 1.1) since c is treated 
as a constant, the blood velocity can be calculated if the 
angle of the ultrasound beam is known.
The angle is calculated on the conventional ultrasound 
image screen of these machines using adjustable calipers. 
The change in frequency may be plotted instantaneously 
against time to provide a flow velocity waveform. Volume 
blood flow can however be calculated with the information 
available from the system since measurement of the vessel 
diameter and of the angle of insonation is possible. In 
practice, calculation of the volume of blood flow in a given 
vessel per unit time, although achieved by a number of 
workers who have derived values for blood flow in the fetal 
aorta (Eik Nes, Bruback & Ulsten 1980), is subject to large 
errors. Thus, although there is a high correlation between 
ultrasound methods and electromagnetic methods (Eik Nes, 
Marsal & Kristofferson 1984; Gill 1985) it is now recognised 
that the cumulative errors of measurement of the angle of 
insonation and vessel diameter, including the change in 
diameter over the cardiac cycle, results in cumulative 
errors of 30%, and consequently qualitative methods are felt 
to provide more clinically reliable data. This is the case 
even when pulsed systems are available. Furthermore, as the 
two most frequently investigated circulations, the 
fetoplacental or umbilical artery, and the uteroplacental 
vessels follow tortuous paths the measurement of insonation 
angle in these vessels is not currently possible.
27
b) Continuous wave Doppler
Continuous wave Doppler systems are cheaper, more 
portable and easier to use than pulsed systems. The 
transmitted signal is emitted and received continuously by 
two separate transducers. It is not possible therefore to 
determine if the echo being received is from a superficial 
or deep vessel and although conventional imaging systems can 
be coupled to continuous wave systems the errors of 
insonation angle are subject to even greater error than 
pulsed methods.
Nevertheless the portability and ease of use of
continuous wave systems makes their use attractive and all
the studies described here were performed using such a 
system.
A number of workers have compared Doppler indices 
obtained using continuous wave systems with pulsed Doppler; 
Van Vugt et al (1988) studied umbilical artery waveforms in 
14 uncomplicated pregnancies between 28 and 40 weeks 
gestation and found no significant difference between the 
methods. Brar et al (1988a) reported on 200 patients with 
high risk pregnancies and found a correlation coefficient of 
0.98 for the same indices of umbilical artery waveforms 
measured using continuous wave and pulsed systems. Mehalek 
et al (1988) , in a smaller study of 85 patients, measured
both umbilical and uterine artery waveforms and found a
correlation of 0.93 for the umbilical artery when the 
measurements were made by the same observer. The correlation 
for the uterine artery was 0.57 which was also highly 
significant, and the conclusion reached was that pulsed
28
Doppler systems are not routinely necessary for the 
identification and measurement of umbilical and uterine 
artery waveforms.
The indices used to describe these waveforms will be 
detailed in chapter 4.
Chapter 1.3 
The safety of Doppler ultrasound in obstetrics.
The well recognised adverse effects of ionizing 
radiation on the fetus (Brent 1983) have led to considerable 
interest in the possible adverse sequelae which might be 
induced by exposure in utero to diagnostic ultrasound. It is 
impossible to prove definitively that ultrasound is safe 
(Meire 1987) but the proliferating use of diagnostic 
ultrasound, and Doppler in particular, highlight the need to 
identify any adverse biological effects which may be 
associated with their use.
One of the problems in determining biological effects of 
ultrasound is the lack of standardisation of the power 
output of ultrasound machines and the best indices to use in 
determining this.
Indices of Doppler power output.
The commonly used indices of power output relate to 
pulsed diagnostic ultrasound and describe sound intensity at 
the peak of a pulse of ultrasound (temporal peak, TP) or 
averaged over the time from pulse emission until the 
begining of the next pulse (temporal average, TA). The units 
used are those for power ie. Watts or Milliwatts per square
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centimetre surface area. Since the average pulse of 
ultrasound lasts one microsecond and the intervening period 
until the next pulse is, on average, one millisecond the 
actual exposure time is small compared to scanning time. 
Continuous wave Doppler apparatus has a higher power output 
since sound is being constantly produced.
Power output across the ultrasound beam is not uniform 
and indices which account for this may also be used to 
describe power output; spatial average (SA) is the average 
of the intensity across the beam and spatial peak (SP) 
describes the point of maximum intensity. With continuous 
wave systems power output may be described therefore in 
terms of spatial peak temporal average (SPTA) or spatial 
average temporal average (SATA). Continuous wave apparatus 
in common usage has a SATA intensity of between 10 and 400 
mW/square centimetre.
The importance of Doppler transducer characterisation 
has recently been discussed (Boote & Zagzebeski 1988) and 
was highlighted by Long et al (1987) who demonstrated that 
as many as 20% of continuous wave Doppler transducers were 
unsuitable for clinical use.
Possible Adverse Effects 
Chromosomal Effects
The possible adverse effects of ultrasound, and in 
particular that produced by obstetric diagnsotic ultrasound, 
were first highlighted by a report by Macintosh and Davey 
(1970) who reported an increase in chromosomal aberrations 
in cultures of human white blood cells. They compared a 
number of chromosomal abnormalities, including chromatid
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breaks and achromatic lesions, in cultures exposed to 
ultrasound with a control group of cultures. The authors 
pointed out that the data from their experimental model 
should not necessarily be extrapolated to conclude that 
these abnormalities would occur in clinical practice. 
Nevertheless their preliminary communication provoked 
considerable interest. A large number of workers repeated 
these studies and have been unable to reproduce the results 
obtained by Macintosh and Davey. Eventually the experiment 
was repeated by the principal author and the original 
results were not confirmed (Macintosh, Brown & Coakley 
1975) .
More subtle forms of chromosomal damage which might be 
associated with diagnostic ultrasound were then 
investigated, particularly sister chromatid exchanges. 
Initial reports of such responses following ultrasound 
(Liebeskind, Bases & Mendez 1979) have not been confirmed in 
further studies (Ciaravino et al 1985) In any case, the 
dangers of extrapolating any of the in vitro results to the 
clinical situation are considerable (Barnett & Kossoff. 
1984).
Studies of the effects of ultrasound in the human in 
vivo have been limited? Bause, Niebyl & Sanders (1983) 
investigated maternal erythrocyte fragility following 
Doppler ultrasound monitoring in labour and observed no 
change although the analysis of the data was limited by the 
use of inappropriate control cases.
Physical Effects
Although the evidence for adverse cellular effects in
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vivo is not convincing the recognised associations of tissue 
heating and cavitation following ultrasound exposure are 
well documented (Campbell et al 1984). In vivo data are very 
scanty and the only investigation of heating effects within 
the uterus following diagnostic ultrasound exposure was 
reported by Soothill et al (1987) who inserted thermocouples 
into the pregnant uterus prior to termination of pregnancy. 
No change in the fetal or amniotic fluid temperature was 
observed following ultrasound. These workers also evaluated 
the effect of Doppler ultrasound in these patients and found 
no effect. The specific effects of Doppler equipment have 
not been fully investigated and knowledge of the particular 
effects of the increasing use of obstetric Doppler must be 
obtained as a matter of some urgency (Preston 1988). 
Effects on fetal growth and wellbeing
The effects of diagnostic ultrasound on fetal growth 
have been investigated and the relationships described 
between ultrasound exposure and fetal growth retardation 
appear to relate to shared common risk factors that is, 
ultrasound examinations will be more commonly requested in 
cases of clinically small fetuses (Moore, Diamond & 
Cavalieri 1988).
More subtle effects of Doppler have also been 
investigated; behavioural effects on the fetus have been 
investigated since the observation that Doppler insonation 
increased fetal movement (David, Weaver & Pearson 1975). In 
a well controlled study Doppler was shown not to have any 
such effect (Murrills et al 1983).
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Delayed effects on childhood development
The problems associated with evaluating fetal growth and 
its relationship to ultrasound exposure also apply to later 
potential effects. Neurodevelopmental delay may be a feature 
of the hostile intra-uterine environment which prompted an 
ultrasound examination. Adequate case control studies have 
generally been lacking. Stark et al (1984) did however 
perform such a study and detected no difference in a number 
of outcomes between ultrasound exposed cases and controls. 
These workers looked in detail at adverse physical, 
neurological and developmental effects. Among the variables 
examined were cognitive function, behavioural scores, 
dyslexia and hearing acuity. This extensive study had the 
benefit of twelve year follow up. The more widespread use of 
ultrasound since the first exposure of the index cases means 
that such a controlled study is no longer possible.
Consequently the negative findings are very reassuring.
Ultrasound and oncogenesis
Two large simultaneously published studies 
(Kinnier-Wilson & Waterhouse 1984; Cartwright et al 1984) 
demonstrated no difference in childhood cancers and 
leukaemias between a total of over 2000 cases and 2800
controls.
Although the evidence to date suggests that obstetric 
ultrasound, including Doppler, is without risk to mother or 
fetus the same opinion was held of X rays in pregnancy
(Oakley 1986; Mole 1986) and ideally controlled trials are 
still required although these seem unlikely to be performed 
because of the already widespread use of ultrasound during
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pregnancy.
In the meantime, it seems prudent to use equipment which 
provides reliable data with the lowest possible power 
output.
All the studies described in this thesis were performed 
with a Doptek 4MHz continuous wave Doppler system with 
on-line spectral analysis. This system was coupled to a 
conventional dynamic imaging ultrasound with 3.5MHz
curvilinear transducer. This system has a SATA intensity of
2 2 42.4mW/cm and SPTA of 81.6 mW/cm at a depth of 14mm from
the transducer.
The specific apparatus is illustrated (Figure 1.2).
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fd = 2.f.Cos 0 
c
hence,
v = fd.c____
2.f.Cos 0
Where f is the transmitted frequency and fd the Doppler 
shift frequency. Theta is the angle subtended by the 
ultrasound beam and the direction of blood flow.
V, the velocity of blood, can be calculated when these are 
known, since c, the velocity of ultrasound in human tissue 
is considered as a constant.
Figure 1.1 The relationship between blood velocity and the 
change in frequency o( a returning signal as a result of 
the Doppler shift.
Figure 1.2 Illustration of the ultrasound equipment used in 
the study. A conventional Dynamic Imaging (Livingstone, 
Lothian) "Concept" real time ultrasound scanner is coupled 
to a Doptek continuous wave Doppler apparatus (Doptek Ltd, 
Chichester) with instantaneous Fast Fourier Transformation.
Chapter 2 The uteroplacental and fetoplacental 
circulations in clinical practice.
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Chapter 2
The uteroplacental and fetoplacental circulations in
clinical practice.
The placenta provides respiratory, nutritional and 
excretory functions for the fetus and is anatomically 
defined by the eighth week of pregnancy. By term it is a 
substantial structure weighing, on average, 600g, or just 
over a fifth of the fetal weight. The development of the 
placental circulation is complex, the mesoderm of the 
primary villi giving rise to the ultimate placental 
vasculature which is appropriately rich and interconnected. 
The primitive fetoplacental circulation is formed about half 
way through the second post-conceptional week and the fetal 
heart circulates fetal blood from about the fourth week 
after conception (Moore 1982). Placentation invokes a series 
of processes at the implantation site which have important 
implications for the maternal supply to the developing 
pregnancy. Invasion of the decidua by the 
syncitiotrophoblast is an early event which ensures a secure 
nutrient supply for the developing blastocyst (Pijnenborg et 
al 1983). This process continues until, early in the second 
trimester, cytotrophoblast invades the maternal spiral 
arteries. This invasion proceeds until about 24-26 weeks by 
which time the normally tortuous and narrow resistance 
vessels have lost their muscularis layer. This results in 
the formation of flask-shaped low resistance vessels which 
provide a rich and unimpeded maternal blood supply to the 
bed of the growing placenta (Brosens, Robertson & Dixon
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1972; Moll, Kunzel & Harberger 1975; Sheppard and Bonnar 
1981) .
Even though fetal condition is absolutely dependent upon 
the integrity of both the uteroplacental and fetoplacental 
circulations, knowledge about their function and control 
remains limited. The interaction of these physically 
separate but contiguous circulations is undoubtedly complex 
(Figure 2.1) and there is increasing evidence that changes 
in one circulation may modulate changes in the other. 
Certainly, the fetoplacental circulation should not be 
regarded as passive. The placental circulation will respond 
to a number of vasoactive substances such as 5 
hydroxytryptamine and angiotensin 11. and vessel tone 
appears to be controlled by a number of systems at least one 
of which is cyclo-oxygenase dependent. In addition 
angiotensin 11 and atrial natriuretic peptide have been 
located in, and appear to be active in, the placental vessel 
walls (McQueen et al In Press). The role of paracrine 
systems remains unclear but endothelial derived relaxing 
factor has been isolated from cord endothelium and an 
effector machanism has been shown to be present. The role of 
these systems in maintaining placental vessel tone remains 
speculative but it is conceivable that they regulate 
shunting of fetal blood within the placenta to optimise gas 
and nutrient transfer. Some evidence that events on the 
maternal side may influence the fetoplacental unit come from 
experiments using microsphere embolisation of the uterine 
circulation in sheep. The fetal response to the resultant 
diminished maternal blood supply is a parallel reduction in
39
umbilical blood flow (Clapp et al 1981) .
This chapter discusses some of the methodology for 
studying uteroplacental and fetoplacental blood flow and 
some of the determinants which have been identified in 
improving understanding of the vascular physiology and 
pathology of placentation.
Methods of assessing uteroplacental blood flow.
Although pathological disturbances in uterine blood flow 
have been implicated in some pregnancies complicated by 
essential hypertension, pregnancy induced hypertension (PIH) 
and intra-uterine growth retardation (IUGR), no direct data 
exist because of the difficulties in measurement. However, a 
number of strategies have been developed over the years
including clearance rates of endocrine and radioisotope
markers and, more recently, Doppler ultrasound velocimetry.
The findings of Browne and Vealle (1953) , which were 
later confirmed by Dixon, Browne & Davey (1963), did 
suggest that there was a reduction in uteroplacental 
perfusion in some complicated pregnancies. The methods used
measured the rate at which radioisotopes disappeared from
the choriodecidual space, this change correlating with the 
extent of perfusion. The use of radioisotopic methods of 
assessing placental perfusion in humans is no longer 
acceptable not only because of concerns about radioactivity 
but also because technical problems tended to make results 
uninterpretable. For example it has been shown in monkeys 
that the blood supply from the spiral arteries is patchy 
rather than uniform which might invalidate some of the
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radioisotope data. However, recently, Nylund et al (1983), 
using more sophisticated methods, have demonstrated the 
feasibility of studying normal and complicated pregnancies 
using very low radiation dosages although because of the 
nature of these investigations their methods have not found 
widespread acceptance.
Direct measurement of uterine blood flow has been 
performed using electromagnetic flow meters and has provided 
physiologically interesting data. However, the studies were 
performed on pregnancies being terminated by hysterotomy 
(Assali, Rauramo & Peltonen 1960) and could not be used for 
routine investigation. Another invasive method, not yet 
applied to the pregnant uterus, is the use of thermistor 
techniques (Randall et al 1988) but the possible role for 
such an approach remains unclear.
Doppler methods to study the uterine circulation were 
introduced by Campbell et al (1983). Conceptually Doppler 
only provides an indirect measure of flow but it has been 
considered useful in assessing the uteroplacental 
circulation because of the relationship between vascular 
resistance and Doppler indices. Although this relationship 
in the uterine circulation has recently been guestioned 
(Clewell et al 1988) Doppler methods do provide a 
qualitative technique for describing flow velocity waveforms 
which has been widely used to investigate uteroplacental 
perfusion.
Numerous studies have shown the uteroplacental 
circulation to be characterised by low resistance patterns 
in normal pregnancy and high resistance patterns have been
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described in some complicated pregnancies. However, because 
of the non-uniform perfusion of the uteroplacental bed the 
value of the Doppler technique in this circulation remain 
to be established (Redman 1989a). Recent evidence suggests 
that the uteroplacental circulation and the haemodynamics 
within it are more complex than originally thought (Bewley, 
Campbell & Cooper 1989).
The use of colour flow mapping may be helpful since 
uteroplacental vessels can be more clearly identified 
although this currently expensive method has still to be 
adequately evaluated.
Methods of assessing the fetoplacental circulation.
The fetoplacental circulation is established early in 
gestation and, like the uteroplacental circulation, is 
characterised by low vascular resistance.
Invasive methods of measuring fetal blood flow using 
electromagnetic flow meters are of interest and Assali, 
Rauramo & Peltonen (1960), demonstrated a flow rate of 
llOmls/min in the umbilical artery in fetuses being 
terminated by hysterotomy which is about 50% of the total 
cardiac output and highlights the dynamic nature of this 
circulation. Clearly these methods are not appropriate for 
the study of continuing pregnancies and FitzGerald and Drumm 
(1977) and McCallum et al (1978), the pioneers of Doppler 
velocimetry in obstetrics, suggested that Doppler would 
contribute to the understanding of complications such as PIH 
and IUGR. Doppler methods permit non-invasive assessment of 
the fetoplacental circulation but, as with the
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uteroplacental circulation, only qualitative measurements 
can be made.
Pregnancy complications and the measurement of 
uteroplacental and fetoplacental blood flow.
Assessment of uteroplacental and umbilical artery blood 
flow may provide important information concerning both the 
physiology and pathology of these circulations and the 
availability of non-invasive techniques such as Doppler are 
potentially of enormous value. The possible role of Doppler 
lies both in the evaluation of placental circulation as a 
screening tool and in the direct determination of the fetal 
condition in defined disease states. In addition these 
methods may provide an insight into the effects of maternal 
(and fetal ) therapy.
Uteroplacental blood flow in hypertensive pregnancies.
Brosens, Robertson & Dixon (1972) indicated that in 
pregnancies complicated by hypertension the physiological 
invasion of spiral arteries was incomplete. This led to a 
failure to convert the maternal vasculature to a low 
resistance system with the implication that blood flow is 
thereby reduced and inadequate to sustain a pregnancy 
(Gerretsen, Huisjes & Elema 1981).
The concept of placental ischaemia as a factor in the 
pathogenesis of pre-eclampsia had previously led Browne and 
Vealle (1953) to investigate the maternal blood flow using 
Na24 clearance rates. While the definitions that they used 
would not be acceptable today, these workers showed that
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perfusion was reduced in some hypertensive pregnancies. They 
later confirmed their findings using larger numbers 
(Dixon, Browne & Davey 1963) and also observed that the 
changes in blood flow were related to the degree of 
hypertension, being most marked when proteinuria was 
superimposed on hypertension. Using a different isotope, Xe 
133, Kaar et al (1980) confirmed that a reduction in 
intervillous blood flow occurred in pre-eclampsia, although 
there was a wide variation both in normal and complicated 
pregnancies.
Further support for reduced flow in PIH comes from the 
clearance rates of Cl9 steroids which have been shown to 
correlate with uterine blood flow (Edman et al 1981; Senner 
et al 1985) . Gant et al (1971) showed a reduced metabolic 
clearance of dehydro-isoandrosterone sulphate in pregnancies 
complicated by pre-eclampsia and also demonstrated that this 
reduction preceeded clinically detectable disease.
The possibility of identifying changes in perfusion in 
advance of clinical signs prompted Doppler studies of the 
maternal arcuate arteries as a screening test for high risk 
pregnancy. In a study of 126 consecutive women attending 
their antenatal clinic at 16 to 18 weeks gestation Campbell 
et al (1986) showed a higher incidence of IUGR and PIH in 
women with abnormal, compared with normal, uteroplacental 
Doppler waveforms. The very high incidence of abnormal 
waveforms demonstrated in this series and in a later study 
reported by Steel, Pearce & Chamberlain (1988) may be 
spurious and suggests that the normal ranges obtained 
initially were possibly inappropriate for the general
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population to which they were applied. Other workers, who 
have shown differences in uterine artery waveforms from 
either side of the uterus, have suggested that this may 
represent abnormal placentation which might be associated
with hypertension (Schulman et al 1987; Kofinas et al 1988), 
although the basis for this hypothesis is unclear. However, 
Pearce (1987) has reported an association between the
resistance index in the uteroplacental vessels and depth of 
invasion of trophoblast into the spiral arteries.
Unfortunately most studies of Doppler uteroplacental
waveforms in hypertensive pregnancies have studied mixed
populations of patients receiving varieties of 
antihypertensive agents which themselves have unknown
effects on Doppler indices.
In a recent study of untreated cases of PIH the
pulsatility index was no different from matched controls
(Hanretty, Whittle & Rubin 1988a). Although the method of 
obtaining the waveforms has been criticised (Pearce & 
McParland 1988) it was apparent that markedly different
waveforms may be obtained from uteroplacental vessels, a 
finding which probably relates to the focal nature of the 
placental pathology in PIH. Figure 2.2 shows two such
waveforms, one highly abnormal and the other normal, 
obtained synchronously in opposite channels from the
uteroplacental vessels. These waveforms, which were 
unequivocally uteroplacental in origin were obtained from a 
patient with severe PIH. However, uniformly abnormal 
uteroplacental waveforms may be significant and this was 
observed in one of two pregnancies leading to perinatally
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related deaths in the series suggesting therefore that the 
vascular pathology was widespread and severe.
Doppler colour flow mapping of the uterine vasculature
may provide useful information but is still to be fully
evaluated. The clear identification of vessels and direction 
of flow afforded by this method is, however, promising.
In general therefore, it does appear that, in 
hypertensive pregnancy, maternal perfusion of the placenta 
is reduced as demonstrated by a number of different
techniques. Doppler waveforms appear to be abnormal in some 
hypertensive pregnancies and may help to distinguish cases 
of essential hypertension from those with severe PIH, but 
the value of the technique both as a screening test and in 
the assessment of the clinically affected pregnancy is as 
yet unproven and there seem to be major methodological
problems which may limit the application of this technology 
(Redman 1989a).
Fetoplacental blood flow in hypertensive pregnancies.
Almost all of the data concerning fetoplacental blood 
flow has been obtained from studies using Doppler 
velocimetry. However, a recent in vitro study has 
investigated umbilical flow to the placenta in a series of 
10 pregnancies complicated by PIH (Abitbol et al 1987) . 
Although only pregnancies at around term were included, 
suggesting that the disease was relatively mild, these 
workers showed reduced umbilical blood flow compared with 
uncomplicated pregnancies. Placental angiography was 
performed and showed "functional" normality in 79% of
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cotyledons from the control placentas compared with 51% in 
the study group. This highly significant difference also 
highlighted the focal nature of the pathology on the fetal 
side of the placenta.
Extensive in-vivo studies have been performed using 
Doppler to obtain flow velocity waveforms in PIH. A number 
of groups have shown high resistance patterns and reduced 
diastolic flow velocities in some cases but the definitions 
used and the inclusion criteria for study have not always 
been consistent.
Ducey et al (1987) classified the types of hypertension 
complicating pregnancy as chronic, PIH and pre-eclampsia and 
showed abnormal waveforms more commonly associated with the 
last diagnosis. Cameron et al (1988) in a prospective study 
of well defined cases of pre-eclampsia have shown normal 
Doppler indices in 70% of cases with no clear correlation 
between Doppler indices and the absolute level of 
hypertension. Nevertheless, clinical outcome appeared to 
correlate with the waveform as, in cases with an abnormal 
pattern, growth retardation, fetal distress and admission to 
the neonatal intensive care unit were commoner.
The mechanism whereby these abnormal waveforms occur is 
uncertain although it presumably relates to increased 
downstream impedance within the placental vascular tree. 
This may be the result of obliteration of tertiary stem 
villus arterioles (Giles et al 1985; McCowan, Mullen & 
Ritchie 1987; Bracero et al 1989) but whether this is the 
end result of prolonged vasoconstriction or intravascular 
coagulation is not clear. Other factors such as increased
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blood viscosity may be also be important in pathogenesis.
Nevertheless, repeated embolisation of the fetoplacental 
circulation of the sheep fetus has been shown to produce 
Doppler waveforms similar to those seen in severely 
compromised hypertensive human pregnancies (Trudinger et al 
1987a). The production of these waveforms was not associated 
with fetal compromise as evidenced by retarded growth in 
Trudinger's study so it is possible that Doppler methods 
tell us more about the health of the placenta rather than 
about fetal wellbeing directly.
Uteroplacental blood flow in IUGR.
The study by Kaar et al (1980), already mentioned, also 
included a group of babies whose birth weights were less 
than the 10th centile for gestational age and showed a 
reduction in perfusion in these cases. More recently, Nylund 
et al (1983) in a study of small-for-gestational-age babies 
and matched controls used intravenous Indium 113 and 
demonstrated reduced scintillation counts over the placental 
site. A uterine blood flow index was derived and in the 
small-for-gestational age fetuses was less than half that of 
the values obtained from controls. This difference remained 
significant when a group of pre-eclamptics, in whom reduced 
flow might be attributable to a recognised pathology, were 
removed from the series. Six of thirty cases were 
complicated by fetal abnormality and although there was no 
difference in blood flow index between the normally formed 
and abnormal fetuses, it remains unclear what proportion of 
otherwise unexplained IUGR is associated with reduced
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uterine blood flow.
Although Doppler waveform indices in the uteroplacental 
circulation also appear to be abnormal in some cases of IUGR 
(Trudinger et al 1985a; McCowan et al 1988) the results are 
variable and the methodological criticisms mentioned in 
relation to hypertension make the observations of dubious 
significance in clinical practice. However, it would not be 
surprising if widespread pathology in the spiral arteries 
was associated with severe IUGR and waveform abnormalities.
Fetoplacental circulation in IUGR.
Re-distribution of blood flow within the fetal
circulation is a likely feature of "placental insufficiency" 
which may result in growth retardation. Whether increased 
vascular resistance in the placenta is a cause or
consequence of this redistribution is not clear but, as in
some cases of hypertension, abnormal Doppler waveforms have 
been described from the umbilical arteries of growth
retarded fetuses. Erskine and Ritchie (1985) demonstrated
abnormal waveforms in a small series of severely growth
retarded fetuses and considerable interest was aroused in
the potential use of Doppler to identify these high risk 
cases. Furthermore, from their work, it seemed that Doppler 
might identify cases of genuine growth retardation with 
fetal compromise rather than fetuses which although 
small-for-dates show normal growth velocity and are well.
One problem in the evaluation of Doppler velocimetry in 
the identification of the small-for-dates fetus is the 
appropriateness of the end-point. Thus many studies are
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faulted by the use of birthweight charts not derived from 
the population under study. Not surprisingly the data from 
Doppler studies are conflicting: in 168 high risk cases
Berkowitz et al (1988a) demonstrated a sensitivity of 45% 
when using umbilical artery Doppler to identify fetuses 
weighing less than the tenth centile at birth. Mulders et al 
(1987) in a smaller series obtained a corresponding figure 
of 53%. In contrast, Gaziano et al (1988) showed abnormal 
waveforms in 79% of such cases. It is possible that Doppler 
may be more useful in identifying the fetus which has failed 
to reach its growth potential but which is not necessarily 
small-for-dates and preliminary data from an on-going study 
of umbilical artery Doppler in an unselected population 
tends to confirm this (Hanretty et al 1989) . This will be 
further discussed in chapter 6.
However, most studies strongly suggest that umbilical 
flow abnormalities detected by Doppler in the already 
small-for-dates fetus may identify those at increased risk 
for perinatal morbidity and mortality (Reuwer et al 1987, 
Berkowitz et al 1988b).
Doppler assessment of umbilical artery blood flow and the 
identification of fetal wellbeing in high risk pregnancy.
Doppler study of the umbilical circulation may play some 
role in monitoring the identified high risk pregnancy, not 
only in the familiar problems of hypertension and IUGR but 
also in less common conditions such as rhesus disease 
(Rightmire et al 1986), lupus inhibitor (Trudinger et al 
1988) and diabetes (Bracero et al 1986) and the
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categorisation of pregnancies complicated by severe 
oligohydramnios and fetal abnormality may be aided by 
Doppler evaluation of the umbilical artery (Hsieh et al
1988) .
There is a need for a method which identifies all 
pregnancies at risk in early pregnancy and initially Doppler 
of the umbilical artery appeared promising although many of 
the previously reported studies are difficult to interpret 
because end-points used to define fetal compromise tend to
be ill defined and to vary between studies. In spite of
reservations about the use of Doppler it does seem that, in
general, normal results are associated with a normal 
perinatal outcome. The situation is less clear when 
velocimetry indicates reduced, absent or reversed diastolic 
flow. Some reports suggest that such findings imply imminent 
fetal demise indicating the need for immediate delivery 
(Woo, Liang & Lo 1987). Others, whilst agreeing that such 
abnormal patterns do indeed signify fetal compromise, 
suggest that they indicate a need for intensive supervision, 
using established monitoring techniques, rather than urgent 
intervention and have shown that the interval between the 
finding of abnormal waveforms and the necessity for delivery 
can vary from hours to weeks (Roche Is on et al 1987) .
The use of Doppler to evaluate high risk pregnancy has 
been studied in a randomised controlled trial by Trudinger 
et al (1987b). Three hundred pregnancies were studied but 
the only difference in outcome parameters between the group 
of patients for whom the result was available to clinicians 
and the control group related to a reduction in the numbers
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of caesarean sections performed during labour in the former. 
The conclusion was that decision making had been improved by 
knowledge of the Doppler results leading to a better 
selection of patients suitable for labour. However, this is 
not supported by the simultaneous observation of no 
difference in rates of induction of labour or elective 
caesarean section between groups.
It is likely that either larger studies with similar 
inclusion criteria or studies of strictly defined higher 
risk pregnancies would be required to have sufficient power 
to demonstrate a difference in fetal and neonatal outcome 
attributable to the availability of Doppler results.
While such studies are essential, and the results 
eagerly awaited, an improved understanding of the 
determinants of Doppler waveforms both in the uteroplacental 
and fetoplacental circulations is required in order to more 
accurately identify specific clinical problems in which the 
technique may be of value. The currently available data on 
uteroplacental and fetoplacental blood flow in IUGR and PIH 
are summarised in Table 2.1. Much remains to be done in 
investigating the possible role of Doppler in these 
conditions. Chapters 5 and 6 describe controlled studies to 
determine the effect of these conditions on Doppler 
waveforms.
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Table 2.1
Uteroplacental and fetoplacental perfusion in IOGR and PIH: 
a synopsis.
PIH 
In Vitro
Steroid clearance
Radioisotopes
Doppler:screening
Doppler:diagnosis
IUGR
Radioisotopes
Uteroplacental
Not Known
Waveforms repres­
enting high resis­
tance to flow seen 
in some cases but 
methodological 
problems signifi­
cant.
Uterine blood flow 
index 44% of normal 
in cases of IUGR.
Fetoplacental
41% reduction in 
umbilical blood 
flow.
Abnormal umbilical 
artery Doppler 
waveforms appear 
to be a feature of 
fetal compromise 
rather than 
diagnostic of PIH.
Not Known
Reduced metabolic Not Known 
clearance rates 
representing red­
uced perfusion 
precede clinical 
disease.
Reduced blood flow Not Known
of up to 60%
demonstrated. No
clear evidence that
ant ihypertens ive s
change perfusion.
Similar incidence Not Known 
of PIH in those 
with normal and 
abnormal utero­
placental waveforms 
when screened at 24 
weeks.
Doppler:screening Fourfold increase Sensitivity of 45%
in small-for-dates in detecting 
cases with abnormal Small-for-dates 
waveform compared fetuses but within 
with normals at 24 this group Doppler 
weeks. does identify some
cases at increased 
risk of morbidity 
and neonatal 
mortality
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Figure 2.1 The inter-relations of the maternal and 
fetoplacental circulations.
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Figure 2.2 Two waveforms obtained synchronously from 
uteroplacental vessels flowing in opposite directions. The 
upper channel shows a vessel of high vascular resistance and 
the lower channel a vessel of low resistance.
Chapter 3 The aims of this thesis.
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Chapter 3
The aims of this thesis
The aims of this thesis are to determine the 
relationships between common clinical problems and 
uteroplacental and umbilical artery Doppler waveforms and 
identify, if possible, the determinants of abnormal 
waveforms in these conditions.
Questions addressed in this thesis.
What are the relationships of the different Doppler 
indices used to describe flow velocity waveforms in 
obstetric practice? (Chapter 4)
Are uteroplacental and umbilical artery flow velocity 
waveforms altered in pregnancy induced hypertension and is 
this influenced by the degree of hypertension? (Chapter 5) 
Are uteroplacental and umbilical artery flow velocity 
waveforms altered in those pregnancies in which the fetus is 
small-for-dates? (Chapter 6)
Does a change in fetal blood viscosity occuring after 
intravascular transfusion for rhesus disease influence flow 
velocity waveforms? (Chapter 7)
Is elevation of maternal serum alphafetoprotein 
associated with a placental lesion which is detectable using 
Doppler methods? (Chapter 8)
Does antihypertensive therapy alter uteroplacental or 
umbilical artery flow velocity waveforms? (Chapters 10 and 
11)
Chapter 4 Methodology of obtaining Doppler waveforms.
4.1 Methods used in this thesis.
4.2 Indices used to describe flow 
velocity waveforms.
4.3 Discussion •
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Chapter 4
Methodology of obtaining Doppler waveforms.
Chapter 4.1 Methods used in the present studies.
All studies described in this thesis were performed 
after informed verbal consent was obtained from the patient. 
Patients were studied in the semi-recumbent position and 
blood pressure was measured frequently using an automatic 
sphygmomanometer (Bard Sentron) to exclude supine 
hypotension.
The Doppler studies were preceded by conventional 
visualisation of the fetus and the umbilical cord 
identified. Doppler waveforms were identified from the 
umbilical artery and when five waveforms of adequate quality 
were visualised on screen synchronously with the umbilical 
venous signal the waveforms were frozen on the screen and 
the systolic, diastolic and mean frequency were obtained for 
each of 5 waveforms. The use of this number of cardiac 
cycles has previously been shown to produce a high level of 
reproducibility (Hastie et al 1988). Figures 4.1a and 
4.1b show representative umbilical artery waveforms. Fetal 
heart rate was also recorded.
The maternal signals were obtained by a process of 
pattern recognition and the waveforms selected were those of 
greatest clarity which represented vessels of low 
resistance. Figures 4.2a and 4.2b show representative 
uteroplacental waveforms. Since a continuous wave system was 
used, and it is not possible to determine the specific 
vessel being insonated, the lowest resistance vessels were
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taken for analysis since high resistance signals could be 
obtained from the iliac and epigastric arteries. This 
approach has been guestioned (Campbell, Vyas & Bewley 1988; 
Fairlie et al 1988; Pearce & McParland 1988) but remains in 
use (Chambers et al 1989) and, given the constraints of the 
continuous wave system, is internally consistent. This will 
be discussed in detail later.
Results of Doppler examinations were not made available 
to clinicians and management was not influenced by the 
performance of the Doppler examinations.
Chapter 4.2 Indices used to describe flow velocity 
waveforms.
Three indices are commonly used to describe Doppler flow 
velocity waveforms qualitatively. These are the 
systolic/diastolic, alternatively referred to as the A/B 
ratio, the resistance index (RI) and the pulsatility index 
(PI) . These indices are illustrated in Figure 4.3. Only one 
large published study has reported on the relationship
between all these indices (Thompson, Trudinger & Cook 1988). 
In this study of 65 patients studied on a total of 133
occasions in the last trimester a high correlation was shown 
between all three indices.
Unfortunately, as this study included multiple 
measurements from the same patients, the values obtained 
were not independent of each other thus invalidating the
correlation coefficients and regression equations obtained.
This point was made by Pearce et al (1988) who reported 
reference ranges of all three indices for uteroplacental and
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umbilical arteries but did not obtain correlations between 
them.
Table 4.1 shows the clinical features of 356 patients 
who had a total of 690 Doppler examinations. The result of 
the last examination was used to determine the relationship 
between the systolic/diastolic ratio (SDR) and pulsatility 
index for both uteroplacental and umbilical arteries.
The reduction in all indices of vascular resistance in 
the umbilical artery with advancing gestation is now well
recognised and reflects a relative increase in the cross 
sectional area of the developing placental vasculature. This 
effect was seen in this series and the effect of gestation
for all patients is shown on pulsatility index, resistance 
index and systolic/diastolic ratio in figures 4.4-4.6. The 
correlations for PI, RI and systolic/diastolic ratio with 
gestational age were -0.49, -0.67 and -0.47 respectively. 
These were highly significant in all cases (p<0.0001) . The 
coefficients of determination were 24% 44.5% and 22%
respectively.
Figures 4.7-4.9 show the same indices for the
uteroplacental circulation plotted against gestational age 
and in this series no relationship between any of the
indices and gestational age was seen.
Table 4.2 shows the correlation between PI, RI and
systolic/diastolic ratio in each circulation. Figures 
4.10-4.15 illustrate the relationships between the indices.
The lack of a linear relationship explains the coefficients
being less than 1.
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Chapter 4.3 Discussion.
The method used to obtain umbilical artery waveforms 
described earlier is standard and widely accepted. More 
contentious is that which has been used to obtain 
uteroplacental patterns. Differences in the uteroplacental 
waveforms have been related to placental site (Chambers et 
al 1988) and the vascular resistance appears to lessen the 
more proximal to the placenta that measurements are made. 
Thus the use of the lowest resistance waveform improves the 
likelihood of signals being obtained from the subplacental 
vessels as has been advocated by some workers (Trudinger, 
Giles & Cook 1985b; Chambers et al 1989). These issues have 
recently been reviewed by Bewley, Campbell & Cooper (1989) 
and it is now realised that the uteroplacental circulation 
is more complex and difficult to characterise than 
previously thought. Consequently a consistent approach, such 
as described here, is required in order to identify the 
determinants of uteroplacental waveforms using continuous 
wave ultrasound.
There is no general agreement about which index best 
describes qualitatively the Doppler waveforms obtained from 
the uteroplacental and umbilical arteries. Thompson, 
Trudinger & Cook have shown high correlations in both normal 
(1986) and complicated (1988) pregnancies and concluded that 
no index was preferable to the others. Like Thompson's group 
the highest linear correlation obtained in in the umbilical 
artery in this series was for RI with PI. This suggests that 
although the calculation of PI theoretically provides more 
information about the whole waveform, rather than just
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maximum and minimum Doppler shift frequencies, the 
additional information has a value.
Thompson and her colleagues point out that this 
relationship may not be the same for other vessels, and in 
this series a better correlation was found in the 
uteroplacental vessels for the systolic/diastolic ratio and 
PI. This reflects the more linear relationship between these 
indices in this circulation.
In this thesis all three indices have been used; in 
chapters 4 and 5 the results from measurement of RI and PI 
have been given. In chapters 7 and 10 the systolic/diastolic 
ratio has been used since, because there were changes in 
fetal heart rate in the studies presented there, corrections 
for this counfounding variable were required and could more 
readily be made. In chapter 9 the number of cases with 
absent end diastolic flow velocities necessitated the use of 
the pulsatility index only.
Statistical methods used in the Thesis.
Data are presented as means with standard deviations 
shown in parentheses unless specifically stated.
Comparisons between groups have been made with paired t 
tests or two sample t tests where data are normally 
distributed, and the Mann Whitney U test or Wilcoxon test 
used if this is not the case. Other statistical methods used 
are described in the relevant text.
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Table 4.1 The clinical features of patients studied.
Suspected Intra-Uterine Growth Retardation 36
Pregnancy Induced Hypertension 112
Normal 179
Maternal Diabetes 2
Systemic Lupus Erythematosus 2
Trisomy 21 1
Trisomy 18 1
Chronic Renal Failure 1
Essential Hypertension 22
356
Table 4.2 Correlations between Doppler waveform indices 
for uteroplacental and umbilical arteries.
Uteroplacental Arteries
RI SDR
PI 0.90 0.98
RI   0.86
Umbilical Artery
PI
RI
SDR
0.61
0.72
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Figure 4.1a Normal umbilical artery flow velocity 
waveform of low resistance.
Figure 4.1b High resistance1 umbilical artery flow velocity 
waveform.
F i g u r e 1 4 . 2 a  I / )w  r e s i s t a n c e 1 ut . c r o p  1 ae:ont a 1 f low v o l c x : i t y  
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figure 4.2b High resistance1 uteroplacental 1low 
^vetorm from a patient with pregnancy 
hypertension.
velocity
induced
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kH z
mean
card iac cycle secs
PI = A-B RI = A-B SDR = A
mean A B
Figure 4.3 Scheme representing the method of calculating 
the pulsatility index (PI), resistance index (RI) and 
systolic/diastolic ratio (SDR) .
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Figure 4.11 Relationship between resistance index and
systolic/diastolic ratio in the umbilical artery.
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Figure 4.12 Relationship between resistance index and
pulsatility index in the umbilical artery.
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Figure 4.14 Relationship between resistance index and
systolic/diastolic ratio in the Uteroplacental arteries.
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Chapter 5 Cross sectional study of umbilical and
uteroplacental flow velocity waveforms in
pregnancy induced hypertension (PIH).
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Chapter 5
Cross sectional study of umbilical and uteroplacental flow 
velocity waveforms in pregnancy induced hypertension (PIH) 
Chapter 5.1 Definitions of PIH.
The association between high blood pressure and the 
eclamptic process was recognised and reported in the English 
language over one hundred years ago in Edinburgh by 
Ballantyne (1885).
The Edinburgh pioneer of antenatal care reported on 
three cases of what were then thought to represent Bright's 
disease and described "sphygmographic traces of high 
tension." It was however eighteen years later that two 
residents in Johns Hopkins hospital suggested that 
sphygmomanometry might predict eclampsia (Seligman 1987) .
Unfortunately this recognition of the importance of 
hypertension has tended to obscure the appreciation of the 
condition as not primarily one of high blood pressure 
(Redman 1989b). Furthermore the emphasis placed on levels of 
hypertension has led to confusion about the level of blood 
pressure which is clinically relevant. Problems associated 
with the actual measurement of blood pressure are also 
significant and both of these problems have recently been 
reviewed as they apply t.o non-pregnant subjects (Kaplan
1987) . Kaplan highlighted the existence of "White-Coat 
Hypertension," that is hypertension induced by its 
measurement by a physician! The rapid settling of initially 
high blood pressure in pregnant women admitted to hospital 
is probably a reflection of this phenomenon rather than a
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genuine disorder.
Even in patients with sustained high levels of blood 
pressure there is still debate about whether the fourth or 
fifth Korotkoff sound should be used to record diastolic 
values. This is of importance in comparing different studies 
both of epidemiology and of treatment.
On average, diastolic blood pressure is 5 to 10 mmHg
greater using the fourth sound than when using the point at
which complete cessation occurs (Seligman 1987) .
Conseguently in studies of PIH the diagnostic criteria and 
the measurement technigue used must be clearly defined.
The commonly used definitions of PIH have been those 
devised for use in epidemiological studies (Redman 1989b) 
and generally comprise three features: hypertension,
proteinuria and oedema. In British practice the level of 
hypertension which has been considered abnormal is 
140/90mmHg or greater (Nelson 1955) occuring in the second 
half of pregnancy, This arbitrary value has the merit of 
being widely used. Gallery et al (1979) have suggested that 
levels greater than 85mmHg diastolic are pathological but, 
in any case, absolute levels may not be informative about 
the prognosis of the disease; an increase in levels of blood 
pressure may be more helpful in predicting disease
progression and some workers have advocated definitions 
based on increases in blood pressure over non-pregnant or 
first trimester levels. Nevertheless, increasing fetal and 
neonatal mortality and maternal morbidity are associated 
with the greater degrees of hypertension (Friedman and Neff 
1977).
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The classification and definition of the hypertensive 
disorders in pregnancy have recently been reviewed and
suggestions made for reclassification (Davey & MacGillivray 
1988; Redman and Jefferies 1988). Davey and MacGillivray 
have suggested that hypertension should be defined as a 
diastolic blood pressure recording of 90mmHg or greater, as 
suggested by Nelson (1955), and that this approach has the 
advantage of simplicity, convenience and is justifiable 
since this level corresponds to two standard deviations
above the mean in the third trimester. Furthermore this
level represents the point of inflexion of the curve
relating perinatal mortality to diastolic blood pressure. 
Redman and Jefferies (1988) suggested that this approach 
biased diagnosis of PIH towards the inclusion of women with 
chronic hypertension. Basing their conclusions on a database 
of over 16000 singleton pregnancies they suggested that an 
increase in blood pressure was a more important diagnostic 
criterion. They suggested that PIH should be diagnosed in 
women who have an initial diastolic pressure of less than 
90mmHg before 20 weeks gestation, a maximum subsequent 
diastolic blood pressure of 90mmHg or more and an increase 
of 25mmHg or more. These workers emphasised the importance 
of the diastolic increment. The American definition (Hughes 
1972) also includes an increment though this is less than 
suggested by Redman and Jefferies (15mmHg).
Although the limitations of all these arbitrary 
diagnostic criteria must be recognised, the absence of a 
universally accepted marker for PIH means that blood 
pressure measurements remain the basis upon which the
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diagnosis of this multi system disease is based.
All patients in the study to be described met the 
following criteria:-
Blood pressure of less than 140/90mmHg before or during the 
first trimester of pregnancy.
Maximum subsequent blood pressure of 140/90mmHg or greater. 
Increase of 15mmHg in diastolic blood pressure or 30mmHg in 
systolic blood pressure over first trimester or non-pregnant 
levels.
Chapter 5.2 The clinical problem of PIH.
The effort which has gone into the classification and 
definition of PIH emphasises the magnitude of the clinical 
problem associated with this condition.
Maternal mortality from PIH, whilst decreasing, remains 
significant. As a proportion of maternal deaths in England 
and Wales , hypertensive diseases of pregnancy increased 
from 12.5% in the triennium 1970-1972 to 18.1% for 
1982-1984, the period for which the most recent data are 
available (Department of Health 1989).
The psychological and physical morbidity associated with 
elective premature delivery in the maternal or fetal 
interest because of hypertension can never be calculated. 
Nor have the costs of hospitalisation been evaluated but 
must be significant since the condition affects 
approximately 5 to 7 percent of pregnancies.
As regards fetal and neonatal morbidity, pregnancy 
hypertension is the leading definable cause of premature 
delivery, and it has been suggested that the rate of
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associated neurodevelopmental defects may be as high as 25% 
(Friedman and Neff 1977).
PIH is associated with twice the number of perinatal 
deaths which are due to placental abruption and the 
perinatal mortality is four times greater than for 
congenital abnormality and five times that of cord prolapse 
(Friedman and Neff 1977; MacGillivray 1983). Although 
enormous effort has been directed at reducing the toll of 
PIH it is unlikely that major improvements will continue to 
be made in the management of this difficult condition until 
more is known about its aetiology and pathogenesis.
Chapter 5.3 The aetiology and pathogenesis of PIH.
The aetiology of PIH remains enigmatic. The multi-system 
nature of the disorder means that as investigators find 
disordered physiology in many different systems confusion 
arises between what is an aetiological factor and what is 
an effect. The following is a brief outline of some of the 
major factors which have been implicated.
Genetic Factors.
The abnormalities which develop in PIH often precede 
pre-clinical disease and the extensive work by Chesley and 
co-workers over many years pointed to the condition being 
"highly heritable" and demonstrated a single gene pattern of 
inheritance (Chesley & Cooper 1986). Different rates of gene 
prevalence might also explain the wide geographic variation 
in the incidence of the condition (Golding et al 1988).
A subsequent report from Chesley's group (Cooper et al
1988) suggested that the fetal genotype might also
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contribute to the maternal susceptibility to the condition. 
Immunological Factors.
The immunology of the trophoblast has been extensively 
investigated and whilst the trophoblast has only low grade 
antigenicity (Petrucco 1981) overloading of the maternal 
immune response with fetal antigenic stimuli may play a role 
in pre-eclampsia. Antigenic overloading has been implicated 
in the higher incidence of PIH in multiple pregnancy and
hydatidiform mole and may explain the association between 
fetomaternal bleeding and the later development of
hypertension in pregnancy (Jones, McNay & Walker 1969) .
Paradoxically there seems to be a closer match between 
women with PIH and their partners for HLA antigens and a 
hypo-responsiveness in mixed lymphocyte cultures against 
paternal antigens. (Jenkins et al 1978) . In vitro
fertilisation studies seem likely to help determine the
contribution of the maternal/paternal antibody-antigen 
interactions occuring in PIH (Serhal & Craft 1989).
Renin Angiotensin System.
It has long been recognised that women at increased risk 
of PIH have increased responsiveness to infused angiotensin 
compared to controls (Talledo, Rhodes & Livingstone 1966) 
and angiotensin 11 may play an important role in controlling 
maternal vascular responsiveness in the condition 
(Broughton-Pipkin 1988). Angiotensin 11 may cause separation 
of endothelial cells and the renin-angiotensin system may be 
involved as a mediator between genetic-immunological factors 
and the vascular damage associated with PIH.
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Prostaglandins.
Other locally acting hormones have been implicated in 
this vascular damage and it seems clear that 
prostacyclin/thromboxane interactions are important 
(Ylikorkala & Makila 1985). These have recently been 
reviewed by Friedman (1988) who found a reduction in 
prostacyclin levels in all fifteen studies of hypertensive 
pregnancies in which diagnostic criteria were given. All 
four studies which reported a prostacyclin/thromboxane ratio 
showed a reduction in severe PIH. Manipulation of the 
arachidonic acid pathway producing these compounds using 
aspirin may reduce the incidence of PIH (Beaufils et al 
1985) but whilst the data from studies of aspirin thus far 
suggest a causative role for prostacyclin deficiency 
(Wallenburg et al 1986) this requires further evaluation. 
Haematological Indices.
Abnormal prostacyclin responses may be responsible for 
the neutrophil and platelet activation seen in PIH (Greer et 
al 1989) and the histological abnormalities of the placental 
bed described in PIH may be explained in part by the 
subclinical disseminated intravascular coagulation seen in 
conjunction with the thrombocytopenia of the disease. 
Uteroplacental Vascular Pathology.
The state of intravascular coagulation has been 
implicated in the reduction in uteroplacental perfusion seen 
in PIH but, as discussed in chapter 2, in some pregnancies 
complicated by PIH the normal physiological invasion of the 
maternal spiral arteries does not occur (Gerretson, Huisjes 
& Elema 1981; Khong, Pearce & Robertson 1986) and this
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finding accounts for the reduced perfusion in some growth 
retarded pregnancies in the absence of hypertension. In
addition to absent "physiological change," atherosis of the 
spiral arteries has also been described in association with 
hypertension. This may also occur in IUGR without
hypertension although this is a contentious issue. In some
hypertensive pregnancies atherosis with inadequate 
physiological change may be found without any apparent
effect of birthweight (Frusca et al 1989). The effect of
atherosis and inadequate physiological change in reducing
perfusion in such pregnancies is now well established but 
the association between an inadequate blood supply and the 
aetiology of the condition, although intensively 
investigated, remains unclear.
Beker compared uterine artery diameters in primigravid 
and multigravid cows using intravascular barium (1929) and 
found reduced size in the former group. Since PIH is usually 
a disease of primigravidas he concluded that maternal
hypertension developing during pregnancy was a response
developed in order to maintain uterine blood flow and showed 
similar findings in human hysterectomy specimens. His 
findings prompted Beker to suggest that the use of the term 
"toxaemia of pregnancy" should be discouraged since all of
the findings could be explained in terms of a response to
reduced uterine perfusion and proposed the use of the word 
hypertonia (Beker 1948) .
It was observations such as these which led to a number 
of studies which aimed to reduce uterine perfusion by 
clamping large maternal vessels, the inferior part of the
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aorta or the uterine arteries themselves, to induce 
hypertension in the pregnant animal. These studies have been 
reviewed by Cavanagh et al (1974) who developed their own 
primate model in which uterine arteries were identified in 
the non-pregnant baboon and clips applied to prevent 
enlargement during pregnancy (Cavanagh et al 1977) . This 
procedure produced hypertension and renal changes typical of 
PIH. It is arguable if this model truly represents the 
type of "uterine ischaemia" occuring in complicated human 
pregnancy (Greiss 1977). Nevertheless, it is clear that such 
a process plays a major role in the pathology of 
PIH.
A scheme representing ways in which different factors 
involved in the aetiology of PIH may interact to alter 
uteroplacental perfusion is presented in Figure 5.1.
Since Doppler velocimetry indirectly measures perfusion 
its use has been proposed to aid the early diagnosis and
investigation of PIH. Before discussing the effect of 
hypertension on Doppler indices it is relevant to briefly 
review some of the techniques which have already been
suggested for this purpose.
Chapter 5.4 Diagnostic methods in PIH.
More than 100 different techniques have been described 
for the early diagnosis of PIH (Sibai 1988). These can be 
categorised as tests which measure blood pressure in
response to a specific stimulus or biochemical or
haematological tests on maternal blood.
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Tests measuring blood pressure responses.
One of the diagnostic dilemmas present in some cases of
PIH is that of distinguishing it from underlying or 
pre-existing hypertension. It was with the aim of 
differentiating these conditions that Chesley and Valenti 
(1958) investigated a battery of tests described previously 
by others as being helpful. These included the blood 
pressure response to cold (the cold pressor test), the 
intravenous administration of tetramethylammonium chloride 
and the response to intravenous vasopressin. Only the last 
measure appeared to discriminate patients with PIH from 
those with chronic hypertension.
None of these tests was however sufficiently specific 
for clinical use. In contrast Gant et al (1974) found that 
93% of normotensive primigravidae who would subsequently 
develop PIH demonstrated an increase of 20mmHg in diastolic 
blood pressure when turned from the lateral recumbent to 
supine position. Support has been given to this work by 
Karbhari, Harrigan & LaMagra (1977) and Phelan (1977) among 
others but not by others (Kassar, Aldridge & Quirk 1980) and 
despite the encouraging results of Gant and colleagues 
studies with false positive rates between 6 and ninety
percent and false negative rates between 4 and thirty
percent have been described (Redman 1982) .
The blood pressure response to infused angiotensin 11 
has a more sound physiological basis as a diagnostic test
and 50% of women destined to develop PIH have a hypertensive
response to infusion. Nevertheless the invasive nature of 
this investigation is too great for routine clinical use.
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None of the tests thus far described are appropriate for 
use as effective techniques for the routine early detection
of PIH.
Tests on maternal blood.
In 1918 Slemons and Bogert reported their findings of a 
study to determine the "placental interchange" of uric acid. 
They found elevated levels in cases of syphilis and pyelitis 
but most noticably in PIH. The biochemistry of uric acid in 
normal pregnancy has since been extensively investigated 
(Dunlop and Davison 1977; Lind, Godfrey & Otum 1984) but 
despite considerable interest it was not until 1956 that 
Lancet and Fisher suggested that uric acid determinations 
could be relied upon in diagnosing PIH. Kuhlback and Widholm 
(1964) suggested that elevated levels of urate were 
prognostically important for fetal outcome. A trend towards 
increasing levels may also be important (Connon and 
Wadsworth 1968) but Redman et al (1977) reported that single 
levels over 0.35 uM/1 were associated with higher perinatal 
mortality rates. Although the mechanism underlying the 
elevated levels of uric acid remains unresolved (Fadel, 
Northrop & Misenhimer 1975) the measurement of urate is now 
a central component of the diagnosis and monitoring of PIH.
An important observation made by McFadyen et al (1986) 
was of an association between plasma urate and vascular 
adaptation in the placental bed. These workers studied 
placental bed biopsies in 34 women for whom uric acid levels 
were available within 72 hours before delivery. The urate 
levels were significantly higher in those women with 
atherosis or inadequate physiological change in the spiral
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arteries. All but one of the 19 hypertensive patients in the 
series had urate value of greater than 300 uM/1. The only
hypertensive patient with a normal urate level was also the 
only patient in that group who did not have atherosis, 
inadeguate physiological change, or both in the spiral 
arteries.
Haematological indices.
Redman used the association between hyperuricaemia and 
PIH to identify women with early onset disease and observed 
a reduction in platelet count resulting from activation of 
the coagulation system (Redman, Bonnar & Beilin 1978). Since 
then regular measurement of platelet count has also become 
standard practice in monitoring pre-eclamptic patients 
although individual measurements are not of diagnostic value 
because of the large variation in platelet count in normal 
pregnancy.
Other diagnostic methods.
The possible role of uteroplacental and umbilical artery 
Doppler in the diagnosis and management of PIH has been
discussed briefly in chapter 2 but one application of the 
Doppler technique which may be of value in the early
diagnosis of PIH is the study of flow velocity waveforms in 
the maternal renal artery. Tyrrell, Bates & Lilford (1987) 
have reported one patient in whom the renal artery
resistance index was elevated before the development of 
abnormal uteroplacental and umbilical artery waveforms. They 
suggested that this was an effect of the condition on renal 
perfusion rather than evidence of primary renal disease. 
Further investigation is required to confirm the value of
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this promising approach.
The value of Doppler velocimetry of the uteroplacental 
and umbilical arteries in the management of PIH remains to 
be determined in sufficiently powerful controlled trials, 
but before these can be designed it is important to 
determine if PIH does influence flow velocity waveforms and 
if the finding of abnormal patterns is related to the degree 
of hypertension. The remainder of this chapter describes a 
study addressing this issue.
Chapter 5.5 Patients and methods.
Patients who met the criteria for the diagnosis of PIH 
defined in chapter 5.1 were invited to undergo Doppler 
examination. No patient was receiving antihypertensive 
therapy at the time of study.
Since blood pressure was regularly monitored before and 
during Doppler study a number of patients who failed to meet 
the strict blood pressure criteria were excluded at this 
stage.
Furthermore because of the limitations of inclusion 
criteria based on blood pressure measurement, data were only 
analysed for the 44 patients with elevated serum uric acid 
values measured within 72 hours before Doppler studies. A 
level of 350 uM/1 or greater was considered as indicating 
hyperuricaemia. This criterion has the value of identifying 
patients in whom the disease process is likely to be 
associated with failure of physiological change or atherosis 
in the maternal spiral arteries (McFadyen et al 1986) . 
Patients with proteinuria detected on ward testing had this
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confirmed by quantitative analysis on 24 hour urine 
specimens. Greater than 500mg was considered significant.
Each patient was matched to within 2 years for maternal 
age and to within 10 days for gestational age with a 
control. The controls were normal volunteers who had no 
complications during pregnancy and who delivered 
appropriately grown fetuses with Apgar scores of greater 
than 6 at one and five minutes at term. Data which were 
normally distributed were compared using a two sample t test 
and those from non-parametric data were compared using a 
Mann Whitney test.
Chapter 5.6 Results.
Table 5.1 summarises the results obtained from 
hypertensive and control cases. For ease of presentation 
data are presented as means and standard deviations even 
when non-parametric analyses have been used.
The mean gestational age at delivery of 36.4 (3.8) weeks 
in the hypertensive group was significantly less than that 
of that of the controls which was 39.4 (1.1) weeks (t=5.0: 
p<0.0001) .
Fourteen of the hypertensive cases were delivered 
pre-term. Seven babies born in the hypertensive group 
weighed less than the fifth centile and four died as a 
result of the effects of prematurity and IUGR.
Uteroplacental waveform indices were significantly 
higher in the hypertensive group compared with controls.
Although in the hypertensive group overall there was 
no significant difference in umbilical waveforms from
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controls, when the Doppler results from the 22 proteinuric 
cases were compared with controls the Doppler indices for 
the umbilical artery were significantly higher (W=954, 
p<0.04 for the pulsatility index and W=921, p<0.02 for the 
resistance index).
Absent end-diastolic velocities in the umbilical artery 
were found in five cases, all of which had proteinuria. In 
four of these cases intra-uterine or neonatal death occurred 
In the fifth case a growth retarded fetus was delivered 
which, like the other babies in the study, subsequently did 
well. There was no consistent relationship between these 
abnormal umbilical artery patterns and high resistance 
patterns in the uteroplacental waveforms.
There was no correlation between levels of blood 
pressure and any Doppler index in either of the circulations 
studied.
Chapter 5.7 Discussion.
The findings presented here report the first controlled 
study of the effects of PIH on both uteroplacental and 
umbilical waveforms measured simultaneously.
Previous studies of the effects of PIH on Doppler 
uteroplacental waveforms have generally supported the 
earlier radioisotope studies showing reduced uterine 
perfusion discussed in chapter 2. The only published 
controlled study failed however, to demonstrate any 
difference from controls (Hanretty, Whittle & Rubin 1988a). 
However, one of the findings in that study was the presence 
°f abnormal waveforms in a pregnancy resulting in
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perinatally related death. It was suggested (Campbell, Vyas 
& Bewley 1988) that, although the vascular pathology of PIH 
was focal, in severely affected cases it is widespread and 
therefore might be expected to result in failure to detect 
waveforms of low vascular resistance. Despite the use of the 
same inclusion criteria as those in the earlier study of 
Hanretty, Whittle & Rubin, a higher proportion of cases with 
early onset disease were recruited by chance and it is 
possible that in these cases the vascular pathology was more 
widespread. Additionally the study presented here is larger 
and in statistical terms more powerful and confirms the 
findings of earlier uncontrolled studies which had included 
patients receiving antihypertensive medication with unknown 
effects on Doppler velocimetry (Campbell et al 1983; 
Trudinger, Giles & Cook 1985a; Fleischer et al 1986).
Only in the proteinuric cases were the umbilical artery 
waveforms significantly different from controls and this 
suggests that the vascular pathology on the fetal side of 
the circulation results in increased vascular resistance 
only when the maternal vascular damage is extensive.
There was no correlation between absolute levels of 
either systolic or diastolic blood pressure and Doppler 
indices and this confirms this observation in a smaller 
series of cases of PIH (Hanretty, Whittle & Rubin 1988b).
Whilst these findings confirm the altered haemodynamics 
in PIH the diagnostic value of Doppler studies remain to be 
determined since in both umbilical and uteroplacental 
circulations there is a large normal range with considerable 
overlap between hypertensive and normal pregnancies.
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However, the findings are consistent with those of Cameron 
et al (1989) who demonstrated that the finding of very 
abnormal umbilical artery waveforms is associated with a 
significant fetal morbidity. Such a finding may alter 
management of a pre-eclamptic patient although controlled 
studies are required to determine if this results in an 
improved outcome.
In conclusion, in PIH Doppler uteroplacental waveforms 
show patterns representing higher vascular resistance 
compared with controls. When the disease is severe, as 
defined by the finding of significant proteinuria, umbilical 
artery flow velocity waveforms are also significantly 
different from controls reflecting more severe vascular 
damage in the fetoplacental circulation.
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Table 5.1 Comparison of results from PIH and control 
groups.
PIH Controls Test P Value
Statistic
Maternal age 25.6 (4.9)
Gestational age 35.5 (3.7)
at time of study.
SBP 164 (15)
DBP 96 (7)
Umbilical artery
PI 1.19 (0.62)
RI 0.65 (0.16)
Uteroplacental artery
PI 0.82 (0.53)
RI 0.47 (0.16)
26.1 (4.6) t=0.47 0.64
35.5 (3.7) W=1985 0.82
130 (10) t=12.4 0.0001
73 (9) t=14.1 0.0001
0.91 (0.17) W=1747 0.08
0.58 (0.08) W=1761 0.10
0.58 (0.27) W=1667 0.02
0.40 (0.13) W=1693 0.04
SBP Systolic Blood Pressure 
DBP Diastolic Blood Pressure 
PI Pulsatility Index 
RI Resistance Index
98
Genetic Factors
Maternal
Fetal
Immunological Recognition
Uteroplacental Perfusion
Renin/Angiotensin Vascular Damage
Platelet/Neutrophil Activation
Prostacyclin/Thromboxane Production
Figure 5.1 Factors influencing uteroplacental perfusion in 
Ptegnancy induced hypertension.
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Chapter 6
Cross sectional study of umbilical and uteroplacental flow 
velocity waveforms in pregnancies with small-for-dates 
fetuses.
Chapter 6.1 The clinical significance of the
small-for-dates fetus.
The selection of suitable outcome variables with which 
to assess investigation and management in obstetrics remains 
a major problem. The birth of a baby which is 
small-for-dates has been used for many years although it is 
unsatisfactory for a number of reasons. The definition of 
small-for-dates describes the proportion of a population of 
babies described by a Gaussian curve which lie to the left 
of a chosen centile; traditionally the tenth centile has 
been used but many normal babies then meet the criterion for 
being small-for-dates. The lower centiles, below the fifth 
and third particularly, are much more likely to include 
babies from pathological pregnancies (Reuwer et al 1987).
Apart from being constitutionally small, babies may be 
born small for a number of reasons including intra-uterine 
infection, structural and chromosomal abnormality, maternal 
smoking drug abuse and poor diet and placental insufficiency 
producing IUGR.
Regardless of the cause for being small-for-dates such a 
fetus is more likely to be compromised in utero and to have 
greater mortality and morbidity than the appropriately grown 
fetus. It is difficult to quantify the increased risk for 
these fetuses because of varying diagnostic criteria used by
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different workers and earlier failure to recognise the 
condition of growth retardation as distinct from prematurity 
as well as absence of long term follow-up data. Patterson et 
al (1986), in their study of 44000 patients demonstrated 
that babies born below the tenth centile after 30 weeks 
gestation contributed around 30 percent of the cases
regarded as having a poor perinatal outcome and this figure 
varied little over the gestational age range. It is likely 
that, as well as including abnormal fetuses, this figure 
represents some morbidity associated with IUGR.
In the perinatal period the small-for-dates fetus
suffers an excess of intra-partum hypoxia and the neonate 
more commonly experiences hypoglycaemia and hypocalcaemia in 
immediate postnatal life (Chiswick 1985). The longer term 
outcome is still inadequately evaluated, although it is
recognised that neurodevelopmental outcome is poorer in the 
small-for-date fetus (Taylor & Howie 1989). The more recent 
literature suggests that the evidence is not by any means 
unequivocal but there are many problems in the design of 
these large retrospective studies relating to power 
calculation and inclusion and exclusion criteria. 
Nevertheless identification of the compromised 
small-for-dates fetus before the onset of labour appears to 
be important since small-for-dates fetuses account for more 
than half of intrapartum fetal deaths (Mcllwaine et al 
1979) .
This probably relates to the inability of the 
small-for-dates fetus to sustain adequate acid base balance 
in labour. Percutaneous umbilical blood sampling, which has
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been advocated in the management of the severely growth 
retarded fetus, both to determine fetal karyotype and acid 
base balance, confirms that acidosis may precede labour; 
Pearce and Chamberlain (1987) reported this finding in 8 of 
10 cases undergoing sampling and substantiated their results 
with blood taken from the umbilical vein at delivery.
Chapter 6.2 The aetiology and pathogenesis of IUGR.
The recognition that IUGR may be a diagnosis in some low 
birth weight babies is a relatively recent event. Many of 
the large early studies of outcome of low birth weight 
babies failed to recognise initially the difference between 
appropriately grown preterm babies and those who were growth 
retarded, or both. This was in part because of the 
uncertainty of gestational age.
The step forward in understanding that "intra-uterine 
malnutrition" could result in the birth of a full term low 
birth weight baby was critical to the investigation of 
abnormalities of growth in utero.
Factors determining fetal size, rather than growth, had 
already begun to be investigated and in the previous decade 
it had already been shown that the maternal, rather than 
paternal, genetic contribution was a determinant of birth 
weight. In a series of cross breeding experiments using 
horses and ponies Walton & Hammond (1938) had demonstrated 
the dominant maternal effect on fetal size. They showed that 
the birth weight of a cross between these animals correlated 
with the breed of the mother regardless of species.
In the human there are familial trends in birth weight
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(Johnstone & Inglis 1974) which support this, the risk of a 
woman delivering a low birth weight baby being increased 2.4 
fold if she herself was of low birth weight. However, the 
influence of genetic, as opposed to environmental effects, 
on birthweight has recently been questioned. Carr-Hill et al 
(1987) showed, from the Aberdeen maternity and neonatal 
database, that genetic influences and genetic factors play 
only a small part in determining birth weight.
Genetic abnormalities and certain intra-uterine 
infections also operate and may retard fetal growth by 
affecting intrinsic growth control through the genomic 
defect or by infecting rapidly reproducing cells.
The genetic control of growth is undoubtedly disturbed 
in some chromosomal defects such as trisomies, sex 
chromosome abnormalities and mosaics all of which have lower 
mean birth weights even when corrected for gestational age 
at delivery. Certain other structural abnormalities 
anomalies such as renal agenesis and heart disease are also 
associated with growth retardation.
Viral infections such as rubella and cytomegalovirus 
appear to exert their growth retarding effect, not by an 
effect on fetal haemodynamics as seems to be the case in 
non-infectious abnormality (Hsieh et al 1988) , but by a 
combined action of endothelial damage, cytolysis and 
localised necrosis.
Abnormal haemodynamics do play a part in some cases of 
IUGR in multiple pregnancy, where placental vascular 
anastomoses may produce a twin to twin transfusion syndrome. 
Even in the absence of this complication between 15 and 20
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percent of multiple pregnancies are complicated by poor 
growth of one or both twins (Houlton, Marivate & Phi1pott 
1981). It has been suggested that, in these cases, the 
retarded growth is a result of an inadequate uteroplacental 
unit since, when delivered, these babies post-natal growth 
matches or exceeds that of appropriately grown singletons.
Adequate substrate is nevertheless required for both 
placental and fetal growth and there is outstanding evidence 
for the role of maternal undernutrition in producing poor 
fetal growth from data aquired as a result of the siege of 
Leningrad during the Second World War. The prolonged period 
of near starvation for the population resulted in 
substantial reductions in birth weight even some time after 
the seige was lifted, suggesting that nutrition even in the 
early stages of gestation is important to later growth 
(Creasy & Resnik 1989).
Environmental Toxins
It is now well recognised that cigarette smoking, 
alcohol and other drug abuse are associated with fetal 
growth retardation. The mechanisms whereby these toxins have 
their effects is unknown but is presumed to be at a cellular 
level presumably interfering with the complex interactions 
of fetal growth factors.
Pathology of IUGR
These growth factors are themselves dependent on 
adequate uterine perfusion and impaired uteroplacental 
circulation has been implicated in the majority of cases of 
IUGR.
The pathological correlates of growth retardation appear
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to be similar to those of pre-eclampsia. McFadyen, Price & 
Gierrson (1986) found absence of physiological change and 
acute atheroma in the maternal spiral arteries also to be a 
feature of growth retardation in some normotensive cases. 
The effect of such pathological changes on uteroplacental 
perfusion has already been discussed in chapter 5. There 
are, however, difficulties in the interpretation of 
histological abnormality in IUGR.
More readily understood is the well recognised 
association between pre-existing vascular disease such as 
reno-vascular disease, collagen diseases, diabetic 
vasculopathy and poor fetal growth but reduced perfusion may 
still be found in the absence of histological abnormality 
(McFadyen et al 1986) and vasoactive substances such as the 
eicosanoids may play a role (Friedman 1988) as may changes 
in blood viscosity. Thorburn et al (1982) demonstrated 
increased blood viscosity in a group of 16 mothers of 
small-for-dates fetuses as well as in a group of severely 
pre-eclamptic pregnancies. Whilst viscosity might therefore 
have a role in placental insufficiency, Steel et al (1988) 
showed no association between viscosity at high or low shear 
rate and uteroplacental resistance index.
Whether a combination of changes in viscosity with 
ultrastructural changes is responsible for the presumed 
impaired blood flow to the uteroplacental unit remains to be 
determined but ideally a method that would detect the fetus 
at risk of compromise would identify the functional 
abnormality in the fetoplacental unit, something which 
Doppler techniques should, on theoretical grounds, achieve
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and so, consequently, deserve evaluation.
The inter-relationships between the factors mentioned 
and the integrity of the fetoplacental and uteroplacental 
circulations, which might be assessed using Doppler, are 
shown in Figure 6.1.
Any advantages to the use of Doppler must, however, be 
compared with currently used techniques.
Chapter 6.3 Identification of the small-for-dates fetus.
The morbidity and mortality associated with the 
small-for-dates fetus has resulted in the direction of 
considerable effort towards the early recognition of these 
cases. It is generally accepted that clinical methods are of 
limited value in the detection of the small fetus. Clinical 
estimation of fetal weight by palpation is particularly poor 
in the small baby (Loeffler 1967) and although additional 
techniques such as symphysis fundal height measurement were 
originally found to increase the sensitivity and specificity 
of the clinical method (Quaranta et al 1981) their 
performance in clinical practice has been disappointing. In 
addition, the obstetrician's response to the clinical 
detection of a fetus thought to be small-for-dates is 
variable and does not seem to correlate with identified risk 
factors such as growth retardation in previous pregnancies 
or subnormal oestriol levels. (Rosenberg, Grant & 
Hepburn 1982). Consequently a large number of adjunctive 
methods, usually ultrasound based, have been developed in an 
attempt, to identify this population of fetuses. The early 
recognition of a pregnancy at risk of being complicated by
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fetal growth problems is difficult and will only really 
become possible with a greater understanding of the 
aetiology and pathogenesis of the underlying process.
In terms of the currently available diagnostic 
techniques the clinical identification of intra-uterine 
growth retardation is disappointing. Hepburn and Rosenberg 
(1986) found that in clinical practice only 26% of babies 
born below the tenth centile were identified antenatally and 
for each of these babies there were two false positive 
results.
These apparent failures led to adjunctive aids to 
diagnosis which can be divided into biochemical and 
biophysical methods,
a) Biochemical
Before the development of widely available portable high 
resolution ultrasound imagers biochemical evaluation of 
fetal wellbeing was a mainstay of practice and was commonly 
used as a screening test for the small-for-dates fetus. Both 
urinary and maternal serum oestriol measurements were found 
to be in the low to low-normal range in the small fetus but 
the discriminative value of measuring this hormone is poor 
and it has been suggested that measurement of oestriol 
values is of historical interest only (Creasy and Resnick 
1989). Human placental lactogen in maternal serum has been 
shown to be a more specific marker for the recognition of 
the small fetus but in general biochemical methods have been 
superseded by ultrasound (Whittle 1988).
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b) Biophysical
Willocks, a pioneer of ultrasound first suggested that 
it might be used to estimate fetal weight. Campbell & Wilkin 
(1975) derived a formula relating fetal abdominal 
circumference to fetal weight and this has become a 
generally accepted method. Since then a multitude of 
formulae have been suggested which include measurement of 
fetal long bones and attempts at indirect measurement of 
fetal subcutaneous fat using thigh circumference 
measurement. Unfortunately, in practice the error of the 
methods is around 10 percent and there is a wide variation 
in accuracy using any specific technique.
Neilson et al (1984) measured abdominal circumference 
and crown rump length without deriving a fetal weight and 
showed that, when applied as a screening test at 34 to 36 
weeks gestation, a sensitivity and specificity of greater 
than 85% could be achieved. Unfortunately, when the 
technique was applied prospectively in a randomised 
controlled trial, availability of the result did not 
influence clinical practice despite the overall accuracy of 
the method.
The contribution of amniotic fluid volume to the uterine 
size in intrauterine growth retardation has also been 
determined by a number of workers but whilst this technique 
has been extensively investigated it has not been introduced 
widely into clinical practice. Attempts at measurement of 
total intra-uterine volume measurement have also been made 
and seem to have a high sensitivity for detecting the small 
fetus (Giersson, Patel & Christie 1985) but poor specificity
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and has not been widely introduced into clinical practice.
The general dissatisfaction with current methods of 
pregnancy screening has led to considerable research into 
new techniques which may have potential use. One of these is 
Doppler velocimetry and it is interesting that the 
suggestion that the method may be useful in the 
identification of the compromised small-for-dates fetus was 
made initially by FitzGerald and Drumm (1977). 
Unfortunately, there have, however, been no published 
studies to determine if Doppler flow velocity waveforms from 
the uteroplacental and umbilical arteries are significantly 
different from controls in the small-for-dates fetus. The 
following section describes such a study.
Chapter 6.4 Methods.
Thirty two patients with singleton fetuses suspected of 
being small-for-dates were recruited following assessment in 
the Day Unit of The Queen Mother's Hospital. Gestational age 
was established from menstrual data and confirmed by 
ultrasound measurement before 16 weeks gestation in all 
cases.
All had been identified as clinically small, had fetal 
abdominal circumference measurements which suggested a fetal 
weight below the fifth percentile for the local population 
using birthweight data from a large local study (Forbes and 
Smalls 1982) and all delivered a baby weighing less than the 
tenth centile for gestation. Patients with preexisting 
medical disease or pregnancy induced hypertension were 
excluded from the study. The uteroplacental and umbilical 
artery flow velocity waveforms were obtained as previously
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described.
A group of 32 women with uncomplicated pregnancies and 
matched for maternal and gestational age were used as 
control cases. The hypothesis tested was that increased 
vascular resistance to flow in both uteroplacental and 
umbilical circulations of the small-for-dates fetuses would 
produce significantly different Doppler waveform indices. 
When patients had a number of measurements made the last one 
obtained before delivery was used for analysis.
Comparisons between groups were made using Student's t 
test and the Mann Whitney test for normal and non-normal 
distributions respectively.
Chapter 6.5 Results.
The results for both SFD and control groups are shown in 
Table 6.1. For ease of presentation results are expressed as 
means with standard deviations. Figures 6.2 to 6.5 show 
graphically the individual data points.
Of the small-for-dates babies 2 weighed between the 5th 
and 10th centile; of the remainder, 13 (41%) weighed less
than the third centile. There was no difference in Doppler 
uteroplacental waveform indices between the two groups but, 
in contrast, the umbilical artery resistance index was 
higher in the small-for-dates cases than controls. Within 
the small-for-dates group there was no difference in Doppler 
indices between those above and below the 3rd centile for 
gestational age.
Using the criterion of a resistance index of greater 
than 0.67 in the third trimester as being abnormal, as 
suggested by Schulman et al (1985) only 3 of these babies
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had an abnormal pattern.
All of the babies subsequently did well though this size 
of study would be unlikely to detect a significant 
difference in neonatal morbidity (Lilford 1989) .
Chapter 6.6 Discussion
Abnormal uteroplacental and umbilical haemodynamics may 
be associated with intra-uterine growth retardation. These 
haemodynamic changes and their assessment using 
non-ultrasound technology have been previously been 
discussed in chapter 2.
Uteroplacental waveforms
Three main groups of workers have investigated the 
uteroplacental circulation in cases of IUGR: Campbell et al 
(1983) first introduced the technique for this purpose but 
the initial studies were performed on a rather disparate 
group of cases. Pearce (1987) has implied that IUGR 
occurring before 34 weeks is associated with impaired 
uterine perfusion and abnormal waveforms but there is little 
evidence to support this in the literature. Nevertheless, 
the observation by Pearce (1987) of an association with 
depth of trophoblast invasion suggests that Doppler might be 
of value in the identification of cases of IUGR before they 
are clinically obvious. This issue has been considered in 
chapter 2 and will be further reviewed in chapter 8.
Trudinger, Giles & Cook reported initially on 
uteroplacental waveforms in 25 cases associated with the 
birth of a small-for-dates fetus (1985a). Of the total 
number of these cases, 15 had abnormal waveforms with
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reduced diastolic frequencies, representing high resistance 
to flow. The aetiology in these cases is not clear from the 
paper although those cases with severe hypertension were 
described separately.
It was suggested that cases of IUGR could thereby be 
subdivided into those primarily of fetal origin and those 
secondary to poor maternal supply. However, in a larger 
study (Trudinger, Giles & Cook 1985b) including 53 
pregnancies ending in the delivery of small-for-dates 
fetuses the uterine artery waveform was no more frequently 
abnormal in the small fetuses than those appropriately 
grown. The sensitivity calculated from their data (though 
not shown in the paper) was 34.0% and the specificity was 
80.7% for the detection of a small-for-dates fetus using 
their criterion of an abnormal uteroplacental waveform being 
above the 95th centile of their normal range for gestational 
age. When these data are analysed using a chi square test 
the resulting value, 3.56, shows no significant association 
between the character of the waveform, normal or abnormal, 
and being small-for-dates.
McCowan et al (1988) studied Doppler waveforms from the 
uterine arteries in a series of 12 cases of IUGR. In 9 cases 
there was underlying maternal hypertension. In the other 
three cases no cause was found and, in contrast with the 
pre-eclamptic cases the uterine artery waveforms were 
normal.
Chambers et al (1989) obtained a sensitivity of 29% in 
the detection of babies below the 10th centile for 
gestation, though the aetiology and inclusion criteria were
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not stated. Consequently the proportion of cases of IUGR 
associated with reduced uteroplacental perfusion in the
absence of underlying vascular pathology as in pre-eclampsia 
remains unknown. Radioisotope data from Kaar et al (1980) 
and from Nylund et al (1983) suggests that uteroplacental 
perfusion is reduced in IUGR but in the study presented in 
this chapter the Doppler indices from the uteroplacental 
vessels were not different between the study and control 
groups. This is not inconsistent with reduced uterine
perfusion but since it is possible that, as in
pre-eclampsia, vascular pathology in the placenta is focal, 
the data obtained from Doppler interrogation of a relatively 
small part of the uterine vasculature is unlikely to reflect 
the overall degree of vascular abnormality. However, it must 
be stated that the cases of IUGR degree described here were 
not of early onset and all babies subsequently did well. 
Nevertheless a significant proportion were below the 3rd 
centile of weight for gestation and significant vascular 
pathology might be expected in these cases.
Umbilical artery waveforms
In this study, in contrast with the uterine circulation, 
differences in umbilical artery indices were found between 
groups.
Abnormal umbilical artery flow velocity waveforms were 
first described in association with intra-uterine growth 
retardation by Erskine and Ritchie (1985) and since then a
number of workers have confirmed this association although 
this has almost always been observed in cases complicated by 
pre-eclampsia, essential hypertension, connective tissue
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disease, fetal abnormality and multiple gestation.
Abnormal waveforms might logically be expected in cases 
of IUGR since a number of workers have suggested that a 
redistribution of blood flow occurs within the fetus and to 
the placenta (Pearce 1987). Since abnormal umbilical artery 
waveforms seem to indicate placental disease, it is likely 
that the redistribution within the fetus is a consequence of 
a change in fetoplacental perfusion and that this is 
reflected clinically in the brain sparing effect of 
assymetrical IUGR (Campbell & Thoms 1977).
However, none of the published studies have examined 
whether umbilical artery waveforms are abnormal in 
small-for- dates fetuses in the absence of maternal disease 
and none have performed controlled comparisons. The 
interesting finding presented here is that, although 8 cases 
in the study group had a Resistance Index value of greater 
than 0.67, corresponding to a systolic diastolic ratio of 
3.00, which has been suggested as the upper limit of 
normality in the third trimester (Schulman 1987), there was 
a wide range of values for these babies. Since all babies 
did well it is unlikely that those with abnormal waveforms 
were more compromised than the others but this cannot be 
excluded from this study. Reuwer et al (1987) showed that 
perinatal outcome in the small-for-dates fetus did appear to 
correlate with Doppler indices rather than birthweight.
The recognition of the "uncompromised" small-for-dates 
fetus using Doppler seems less promising than had originally 
been hoped. A number of workers have now shown that Doppler 
study of the umbilical artery is relatively poor at
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detecting small-for-dates fetuses as part of a screening 
programme, either applied generally to a population 
(Hanretty et al 1989) or to cases already recognised as at
high risk. This is important since a proportion of babies
who are apparently well, based on standard criteria, may be
at the limit of their reserve and it was such babies that it
was hoped Doppler methods would identify early.
Beattie & Dornan (1989) studied 2097 women attending 
their antenatal clinic at 28, 34 and 38 weeks gestation and 
correlated outcome with Doppler indices of umbilical flow. 
The best index for prediction of a baby born below the 5th 
weight centile for gestation was an abnormal 
systolic/diastolic ratio and the sensitivity obtained was 
only 40% with a specificity of 84%. As these authors state 
"other measures that show poor neonatal nutritional 
state.... were even less well predicted".
Berkowitz et al (1988a) studied 168 women at high risk 
of delivering a small-for-dates baby. Forty-two (25%) 
delivered a baby weighing below the 10th centile and using a 
systolic/diastolic ratio of 3.0 as the upper limit of normal 
in the third trimester obtained a sensitivity and 
specificity of 45% and 89% respectively. This contrasts with 
the study of Gaziano et al (1988), who comparing Doppler 
with conventional ultrasound for the identification of 
babies below the 10th centile, found that 79% of the 
small-for-dates cases had a ratio of greater than 3.0. Of 
these pregnancies, 7.8% were multiple and 34% were 
associated with fetal abnormality.
Dempster et al (1989) measured the systolic/diastolic
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ratio in 205 high risk cases and found an abnormal result in
only 41% of the babies below the 10th centile for gestation
and in a recent report Chambers et al (1989) have shown
that, in the detection of the small-for-dates, abdominal
circumference measurement is more accurate than either 
umbilical or uterine Doppler indices. Like Reuwer et al they 
found that Doppler identified antenatal fetal compromise, 
defined as an abnormal antepartum cardiotocogram 
necessitating delivery.
Benson and Doubilet (1988) have reviewed tha published 
data on all Doppler studies of the identification of IUGR 
and concluded that no Doppler criteria have yet been 
established which permit the sensitive identification of the 
growth retarded fetus. They did point out that the 
accuracies obtained using uteroplacental and umbilical 
artery study have been disappointing but data from study of 
the fetal internal carotid and thoracic aorta are more 
encouraging since thay may indicate a redistribution of 
blood flow within the fetus.
The data from the current study would support the 
hypothesis that there is evidence of increased downstream 
impedance in the placental vessels as reflected in the 
statistically significant differences in umbilical artery 
Doppler indices in the small-for- dates fetus compared with 
controls. This finding need not necessarily result in 
abnormal umbilical Doppler indices or indicate fetal 
compromise. Further work on re-distribution of cardiac 
output within the fetal circulation is required. Because of 
the difficulties associated with determining end-points for
study in the small-for-dates fetus, it is suggested that 
controlled studies such as the one described here, be 
performed to determine the nature of changes in fetal 
haemodynamics.
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Table 6.1 Outcome data for the small-for-dates and control 
groups.
Maternal age
Gestation at 
Delivery
Birth weight
SFD
24.7 (5.5)
38.6 (1.8) 
2.42 (0.39)
Controls
24.8 (5.7)
36.8 (2.6)
39.2 (1.1) 
3.35 (0.35)
Significance
NS
NS
P=0.11
P<0.001
Gestation at time 36.5 (3.0) 
of study
Umbilical artery
PI 1.04 (0.27) 0.88 (0.16) P<0.02
RI 0.62 (0.10) 0.56 (0.08) P<0.02
Uteroplacental Artery
PI 0.52 (0.16) 0.61 (0.30) NS
RI 0.38 (0.15) 0.39 (0.13) NS
SFD Small-for-dates 
PI Pulsatility Index 
RI Resistance Index
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Intact Uteroplacental/ 
Fetoplacental Unit
Poor Placentation 
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Toxins
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Growth Potential
Infection
Figure 6.1 Factors influencing fetal growth and their 
relationships with uteroplacental and fetoplacental 
perfusion.
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Figure 6.2 Umbilical artery resistance index in
small-for-dates (SFD) and appropriately grown fetuses
(normals).
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Figure 6.3 Umbilical artery pulsatility index in 
small-for-dates (SFD) and appropriately grown fetuses
(normals).
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Figure 6.4 Uteroplacental artery resistance index in
small-for-dates (SFD) and appropriately grown fetuses
(normals) .
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Figure 6.5 Uteroplacental artery pulsatility index in
small-for-dates (SFD) and appropriately grown fetuses
(normals).
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Chapter 7 The effect of percutaneous umbilical blood 
sampling and intravascular transfusion 
for rhesus disease on umbilical artery flow 
velocity waveforms.
7.1 Blood flow and viscosity.
7.2 Doppler and rhesus disease.
7.3 Methods and patients.
7.4 Results.
7.5 Discussion.
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Chapter 7
The effect of intravascular transfusion for rhesus disease 
on umbilical artery Doppler flow velocity waveforms.
Chapter 7.1 Blood flow and viscosity.
Although the mechanisms underlying the changes in
Doppler umbilical artery waveforms in some compromised
pregnancies are incompletely understood, changes in one 
important determinant of blood flow, blood viscosity, have 
been described in association with abnormal waveforms 
(Giles, Trudinger & Palmer 1986).
The viscosity of a liquid is the intrinsic resistance to 
flow which is a function of friction between its component 
particulate and molecular parts (Lowe 1987). From the
Hagen-Pouseille equation, flow and viscosity are inversely 
proportional and, in general this holds for blood flow in 
vivo although this relationship is only strictly applicable 
to Newtonian fluids in linear vessels of fixed diameter. 
Newtonian fluids are those in which shear rate and shear 
stress are directly proportional. Shear stress is the force 
applied to a fluid layer which, in linear flow, produces 
movement of one layer relative to an adjacent layer. 
Replogle, Meiselman & Merrill (1967) have used the analogy 
of a deck of playing cards to describe shear stress as the 
horizontal force required to move a card relative to those 
below and the shear rate as the distance covered per second 
by the card relative to its neighbour. Plasma and water, 
being Newtonian fluids have a shear rate directly 
proportional to the shear stress thus viscosity remains the
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same regardless of shear rate. In Non-Newtonian fluids, such 
as blood which is particulate, viscosity varies at different 
shear rates and even within the cardiovascular system shear 
rates vary such that blood viscosity is usually reported at 
high and low shear rates.
As well as shear rate, temperature, plasma viscosity, 
and red cell deformability and aggregation play a role in 
determining blood viscosity. Haematocrit is also one of the 
major determinants of viscosity but is independent of these 
factors. Because of these many elements there are 
methodological problems associated with measurement of fetal 
and neonatal whole blood viscosity (Joupilla, Kirkinen & 
Puukka 1986) but, since a linear increase in haematocrit is 
associated with a logarithmic increase in viscosity (Lowe 
1987) and its measurement is independant of shear rate, the 
haematocrit can be used as an indirect index of viscosity at 
all shear rates.
A high haematocrit, such as that seen in neonatal 
polycythaemia, is associated with hyperviscosity syndrome 
with reduced blood flow and increased infant mortality 
(Mentzer 1978). The common associations of neonatal 
polycythaemia are related to increased erythropoeisis and 
include placental insufficiency, pre-eclampsia, chromosomal 
abnormality and chronic maternal lung disease. Foley, 
Collins & MacDonald (1983) have shown an increased 
haematocrit in fetuses becoming acidotic in labour, 
regardless of whether they were growth retarded and 
suggested that chronic hypoxia was the major aetiological 
factor in hyperviscosity. They also suggested that
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measurement of fetal blood flow might identify fetuses at 
risk of hypoxia and acidosis.
Tenenbaum et al (1983) addressed the association between 
blood flow and polycythaemia and hyperviscosity in the sheep 
fetus. In their study of 8 chronically instrumented fetuses 
they induced relative polycythaemia by isovolaemic exchange 
transfusion and recorded a reduction in umbilical blood 
flow. In the human, Jouppila, Kirkinen & Puukka (1986) 
measured cord blood haematocrit and high shear rate 
viscosity in 64 fetuses who had undergone measurement of 
umbilical venous blood flow by Doppler ultrasound in utero. 
They found a significant negative correlation between 
umbilical venous blood flow and whole blood viscosity in 
babies defined by them as having chronic fetal distress.
This evidence is strongly suggestive of a role for 
increased blood viscosity in producing abnormal blood flow 
and Doppler umbilical artery waveforms and Giles, Trudinger 
& Palmer (1986) found a higher haematocrit in a group of 21 
fetuses with abnormal umbilical artery Doppler 
systolic/diastolic ratios when compared with 33 fetuses in a 
similar high risk group but with normal waveforms.
Despite this evidence for an association between blood 
viscosity and fetal blood flow there is very little 
information about the effect of blood viscosity in isolation 
in utero on Doppler waveforms in the human.
A suitable model to study the effect of changes in blood 
viscosity on Doppler waveforms is the anaemic 
rhesus-affected fetus, undergoing intravascular in-utero 
transfusion.
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Such pregnancies are not complicated by blood 
hyperviscosity but nevertheless large increases in blood 
viscosity must ensue from the elevation in haematocrit which 
results from transfusion. This clinical situation therefore 
provides an interesting therapeutic experiment with which to 
test the hypothesis that such an increase in viscosity 
should result in a change in the Doppler waveform. A number 
of studies have now been reported concerning Doppler indices 
and rhesus disease from the opposite perspective, that is, 
the use of Doppler to assess the severity of anaemia and to 
indicate the need for intrauterine treatment.
Chapter 7.2 Doppler and rhesus disease.
Cordocentesis under ultrasound guidance is currently the 
method of choice not only to evaluate the extent of fetal 
anaemia but also to provide a route for transfusion (Whittle 
1989; Rodeck and Letsky 1989) . This method is safer and less 
invasive than the fetoscopic approach (MacKenzie et al 1987) 
but a non-invasive method of assessing fetal condition would 
be clearly desirable and both Rightmire et al (1986) and 
Copel et al (1988) have studied fetal aortic blood 
velocities as a means of predicting the severity of 
haemolytic disease and have produced formulae relating 
Doppler parameters to fetal haematocrit.
Copel et al also noted a decrease in the 
systolic/diastolic ratio in the umbilical arteries in babies 
undergoing intravascular transfusion. This is of course just 
the opposite of what might be expected, the increase in 
haematocrit and hence viscosity, being anticipated to cause 
an increased resistance to flow and therefore an elevated
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systolic/diastolic ratio. However, they did not study a 
group of fetuses undergoing fetal blood sampling alone and 
conseguently the effects attributable to the cordocentesis 
procedure alone were disregarded. In a prospective study of
the accuracy of the formulae which they had previously
derived, Copel et al (1989) failed to show an association
between Doppler indices and the fetal haematocrit but did
nevertheless highlight the evidence supporting the effect of 
blood viscosity on fetal blood flow.
To determine the effect of acute changes in haematocrit 
and conseguently, of viscosity, on fetoplacental blood flow, 
as assessed using Doppler velocimetry, it is necessary to 
compare results from cases undergoing intravascular 
transfusion with cases undergoing cordocentesis for other 
reasons. The following section describes such a study.
Chapter 7.3 Methods and patients
Flow velocity waveforms were obtained from the umbilical 
artery in 20 patients who underwent a total of 35 
percutaneous umbilical blood sampling procedures. This was 
performed in 16 cases to assess the severity of rhesus 
haemolytic disease, and on 22 occasions intravascular 
transfusion was indicated by the results obtained; on three 
occasions blood samples were obtained to provide a rapid 
fetal karyotype, and in one case to determine the fetal 
adenosine deaminase activity.
Premedication with lorazepam, papaveretum and fentazine 
was used in all but three cases. Measurements were made 
after premedication and immediately before the procedure.
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Pre-transfusion and, when possible, post-transfusion 
haematocrits were recorded. The systolic/diastolic ratio and 
fetal heart rate were measured from the umbilical artery 
flow velocity waveform before the procedure and one hour 
after beginning sampling as described in chapter 4. The 
systolic/diastolic ratios obtained were corrected for fetal 
heart rate using the formula reported by Mires et al (1987). 
Comparisons were made between pre and post procedure values 
by Wilcoxon test. The values from the transfused fetuses 
were compared with those who had blood sampling without 
transfusion, using the Mann Whitney test.
Chapter 7.4 Results.
The mean haematocrit before transfusion was 23.6 (8.7)%, 
and the mean increase in haematocrit was 17.1 (6.5)% (n=20)
following a mean infusion of 49.2 (26) mis of packed cells. 
The mean percentage increase in fetal haematocrit was 103 
(87)%. There was a reduction in fetal heart rate after all 
but 2 transfusions (mean heart rate 144 (6.8) before and 139 
(8.8) at 1 hour: p<0.03 ) but no trend was observed in heart 
rate in the fetuses who had cordocentesis alone (mean heart 
rate 143 (6.7) before and 144 (9.9) at 1 hour) (Figures 7.1 
and 7.2) . This difference in response was significant 
(p<0.04).
Both sampled and transfused groups showed reductions in 
the systolic/diastolic ratio following the procedure; the 
corrected systolic/diastolic ratio was 3.65 (1.27) before
sampling alone and 3.08 (0.8) at one hour and 3.4 (1.0)
before transfusion and 2.95 (0.8) at 1 hour: (p<0.03 for
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both groups) (Figures 7.3 and 7.4) and there was no 
significant difference in response between the two groups. 
Even when the systolic/diastolic ratio was not corrected for 
heart rate there was a fall in the ratio following sampling 
alone and a similar reduction following transfusion though 
this did not reach statistical significance; the uncorrected 
systolic/diastolic ratio before sampling alone was 3.61 
(1.35) and at one hour was 3.03 (0.91) (p<0.0.03) and the
corresponding figures for transfusion cases were 3.33 (1.05) 
and 2.96 (0.86) (p=0.07).
Chapter 7.5 Discussion.
Although Doppler velocimetry has been used in 
pregnancies affected by rhesus isoimmunisation to assess the 
need for fetal intravascular transfusion only two previously 
reported studies have investigated the effect of 
intravascular transfusion on Doppler indices. Copel et al 
(1988) showed a negative correlation between haematocrit and 
the umbilical artery systolic/diastolic ratio but did not 
include a group of patients who had blood sampling alone and 
concluded that this was of questionable clinical 
significance.
More recently, Weiner & Anderson (1989) studied the 
effects of cordocentesis with and without fetal curarisation 
and of intravascular transfusion on the umbilical artery 
waveform. They noted significant reductions in the 
systolic/diastolic ratio and the pulsatility index following 
both blood sampling alone and with transfusion. Their 
conclusions were limited but they suggested that, if
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temporal factors could be excluded, this apparent reduction 
in vascular resistance was procedure-related. Unfortunately 
they did not initially comment on any changes in fetal heart 
rate related to the procedures although they mention that 
this could in theory have an effect on the Doppler indices.
In this study a reduction in fetal heart rates was 
observed following transfusion though not after sampling 
alone. In a subsequent report of their results on heart rate 
changes following cordocentesis (Weiner 1989) Weiner & 
Anderson also found that there was a difference in response 
between their transfused cases and those who underwent 
cordocentesis alone. The reason for this difference is not 
known but since a reduction in fetal heart rate might be 
expected possibly to increase the systolic/diastolic ratio 
the formula described by Mires et al (1987) was used to 
correct for heart rate changes. The issue of correcting the 
systolic/diastolic ratio for changes in fetal heart rate is 
contentious. In recent studies both Morrow et al (1989) and 
Mansouri, Gagnon & Hunse (1989) agreed that alterations in 
fetal heart rate affected the Doppler waveform. Morrow and 
colleagues felt that in clinical practice correction for 
heart rate was unimportant whilst recommending that 
correction be made when using Doppler in the research 
setting. Mansouri et al felt correction was required for 
heart rates outside the normal range. Both groups commented 
that the relationship between these variables may also be 
influenced by a change in placental vascular resistance in 
response to heart rate changes. Notwithstanding these 
observations and the fact that in all cases reported here
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the fetal heart rate was in the normal range before the
procedure, correction for fetal heart rate was made because 
of the different heart rate responses between the two 
groups.
This study has shown that umbilical cord blood sampling 
is associated with a reduction in the systolic/diastolic 
ratio whether or not accompanied by intravascular
transfusion. However, the fetuses reported here were not 
representative of the polycythaemic, growth retarded,
chronically hypoxic fetus which might be expected to have
abnormal Doppler indices. Nevertheless it is concluded that,
in the conditions of the study, an increase in haematocrit 
is not associated with an increase in vascular resistance to 
flow as detected by Doppler velocimetry. The hypothesis that 
a humoral vasodilator, perhaps released from the endothelium 
at the time of umbilical cord puncture, may play a role in 
controlling fetal blood flow must be investigated. Atrial 
natriuretic factor (ANF) and 6 keto-prostaglandin FI alpha 
are known to increase following intravascular transfusion 
(Weiner 1989) and ANF in particular may play an important 
cardioregulatory role in the fetus (McQueen et al 1989; 
Castro et al 1989). This hypothesis requires further study.
Since cordocentesis had such a clear effect on 
downstream impedance the hypothesis that a change in blood 
viscosity alone alters waveform indices has not been ideally 
tested but while this also awaits further study it is 
suggested that these findings be considered if umbilical 
velocimetry is used to assess fetal well being following 
umbilical blood sampling or transfusion.
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Figure 7.1 Fetal heart rates before and after 
intravascular transfusion.
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Figure 7.2 Fetal heart rates before and after fetal blood 
sampling alone.
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Figure 7.3 Umbilical artery systolic/diastolic ratios 
before and after intravascular transfusion.
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Figure 7.4 Umbilical artery systolic/diastolic ratios 
before and after fetal blood sampling alone.
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Chapter 8 Umbilical and uteroplacental artery flow 
velocity waveforms in pregnancies with 
high maternal serum alphafetoprotein (AFP) 
measurements.
8-1 The clinical significance of high maternal 
serum AFP levels.
8.2 Methods.
8.3 Results.
8.4 Discussion.
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Chapter 8
Umbilical and uteroplacental artery flow velocity waveforms 
in pregnancies with high maternal serum alphafetoprotein 
(AFP).
Chapter 8.1 The clinical significance of elevated maternal 
serum AFP.
Alphafetoprotein is an alpha globulin synthesised by the 
yolk sac and fetal liver.
Its measurement in pregnancy to screen for neural tube 
defect is well established but the first proposal for the 
use of maternal serum AFP in obstetrics was the
identification of pregnancies at high risk of fetal distress 
and intra-uterine death (Seppalla & Ruoslahti 1972) .
In the absence of fetal abnormality or multiple 
pregnancy, elevated levels of AFP have been associated with 
a number of pregnancy complications: the delivery of low
birth weight babies is significantly commoner in women with 
high AFP levels (Brock, Barron & Jelen 1977; Wald et al 
1977) and this reflects a higher incidence both of
intra-uterine growth retardation (Purdie et al 1983) and
premature delivery (Purdie et al 1983; Hamilton, Abdalla &
Whitfield 1985). Placental abruption and pre-eclampsia are 
also associated with this finding (Hamilton et al 1985; 
Walters et al 1985). A recent study which reviewed the 
outcome of over 13,000 singleton pregnancies screened 
between 15 and 20 weeks (Milunsky et al 1989) reported 
relative risks of 4.0 for low birth weight and 3.0 and 2.3 
for placental abruption and pre-eclampsia respectively. The
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association of high levels of AFP and pre-eclampsia is 
particularly interesting since fetomaternal haemorrhage has 
been implicated in the aetiology of pre-eclampsia (Jones, 
McNay & Walker 1969) and it has been hypothesised that the 
antigenic load to the mother precipitates an abnormal immune 
response. The mechanism whereby AFP is elevated in these 
pregnancies is unclear. Fetomaternal haemorrhage has been 
strongly implicated since Los, De Wolf & Huisjes (1979) 
suggested that evidence of fetomaternal haemorrhage, 
demonstrated by the Kleihauer method, made amniocentesis for 
identification of neural tube defect in pregnancies with 
high AFP, unnecessary.
Abnormalities of placentation may result either in 
increased permeability of placental vessels to AFP or a 
predisposition to fetomaternal bleeding. A recent controlled 
study has shown an increase in placental volume, villous 
surface area and placental infarcts in a small series of 
women with high AFP levels (Boyd & Keeling 1986). Although 
these women had had uncomplicated pregnancies the authors 
suggested that high AFP levels in the absence of recognised 
anomalies was associated with placental lesions which may 
contribute to fetomaternal haemorrhage.
Salafia et al (1988) reported an association between 
elevated AFP levels in mid-trimester and chronic villitis in 
pregnancies complicated by growth retardation, suggesting 
that a specific lesion may be associated with high AFP 
levels.
High maternal AFP levels at 16 weeks gestation are 
associated with a high risk of PIH and IUGR and it has been
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suggested that Doppler velocimetry might identify these 
pregnancies before the onset of clinically obvious disease.
The aim of the study presented here was to establish 
whether elevated maternal serum AFP in the presence of a 
structurally normal fetus is associated with abnormal 
Doppler waveforms from the uteroplacental and umbilical 
arteries.
Chapter 8.2 Methods.
Patients were recruited who had maternal serum AFP 
screening performed as part of the West of Scotland
screening programme and had been referred for detailed
ultrasonography following the finding of a single elevated 
sample, defined as one greater than two multiples of the 
median. Patients were excluded from study if one of the 
following was found
Threatened abortion 
Multiple pregnancy 
Fetal abnormality 
Subchorionic haematomas 
Maternal hypertension
Forty patients met the selection criteria. Doppler
waveforms from the uteroplacental and umbilical arteries 
were obtained as described in chapter 4.
A control group of patients was recruited from women 
undergoing detailed ultrasonography because of past 
obstetric or family history, or women undergoing scanning 
for confirmation of gestational age. Each of the high AFP
142
patients was matched to within one week for gestational age 
with a patient in the control group.
Comparisons were made using unpaired tests as other 
variables could not be excluded as contributing to the 
variation in values obtained. Student's T test was used for 
parametric data and the Mann Whitney test when the data were 
non-parametric.
Chapter 8.3 Results.
The mean gestational age at the time of study was 19.5 
(1.6) weeks in the high AFP group and 19.5 (2.3) in the
controls. As a result of the matching these were not 
significantly different.
The mean gestation at delivery in the AFP group was 38.0 
(3.2) weeks and in the control group was 39.1 (1.3) weeks
t=1.96, p=0.05). The birth weights were 3.08 (0.6) Kg and
3.52 (0.55) Kg in the same groups respectively (t=3.46, 
P<0.001).
Table 8.1 summarises the outcomes in the pregnancies 
studied. Complications were significantly commoner in the 
high AFP group.
The mean umbilical artery pulsatility index was 1.48 
(0.34) and was not significantly different from the control 
group value of 1.44 (0.39). The resistance index was 0.79 
(0.07) and 0.76 (0.07) for the same groups and were again 
not significantly different.
Similarly, the mean uteroplacental pulsatility index was 
0.64 (0.42) and 0.63 (0.62) in the AFP and control groups 
respectively and were not different. The resistance index in
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these vessels for the same groups were 0.40 (0.12) and 0.39 
(0.14) and again were not significantly different. These 
values are within the normal limits described for the 
gestation of study by Pearce et al (1988) .
Chapter 8.4 Discussion.
Normal placentation, in particular the invasion of 
cytotrophoblast into the maternal spiral arteries to convert 
them into low resistance vessels, begins as early as 12 
weeks gestation and is well established in the second 
trimester. Theoretically, therefore Doppler methods could 
identify pregnancies at high risk of developing the sort of 
complications characterised by failure of this mechanism, 
such as IUGR and PIH (Campbell et al 1986).
The study presented here has utilised the recognised 
association between high maternal serum AFP levels and later 
pregnancy complications. Uteroplacental waveforms were 
similar in both groups and the possible reasons for this are 
discussed in chapter 2. The work of Campbell et al (1986) is 
yet to be substantiated by other workers and although the 
evidence is strongly suggestive, there are no convincing 
data that uteroplacental perfusion is already compromised 
early in pregnancies destined to be complicated. An 
alternative hypothesis is that although there are anatomical 
differences in the uteroplacental vasculature at delivery 
between complicated cases and normal pregnancy, perfusion 
and function may be maintained until the latter weeks of 
pregnancy, when, as shown by radioisotope methods, perfusion 
may fall below normal.
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It is not surprising if this latter hypothesis is 
correct, to find no difference in umbilical artery waveforms 
in early pregnancy. Another possibility, which reguires 
further study, is that the measurements were obtained before 
spiral artery invasion by trophoblast was completed in 
either group. A study performed at 24 to 26 weeks gestation 
should establish whether this factor played a role. 
Unfortunately since many of the patients in the present 
study were referred for detailed ultrasonography from 
elsewhere follow-up throughout pregnancy was not possible.
The hypothesis that elevation of maternal serum AFP 
might be associated with a placental lesion identifiable 
between 16 and 24 weeks gestation using Doppler ultrasound 
is rejected.
This study does add further support to the previous 
studies showing the value of AFP estimation as an indicator 
of later complications but does not support the use of 
Doppler in early pregnancy screening for later 
complications.
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Table 8.1 Complications occuring in the high AFP and 
control groups.
High AFP Controls 
Pregnancy induced hypertension 5 3
Small for dates fetus 4 1
Premature labour 6 1
Intra-uterine death 1 0
Total complication 16 (40%) 5 (12.5%)
CHI squared = 6.46, p<0.02
Chapter 9 The use of Doppler velocimetry in 
developmental pharmacology.
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Chapter 9
The use of Doppler in developmental pharmacology.
Knowledge of the haemodynamic effects of maternally 
administered drugs on the uteroplacental and fetoplacental 
circulations has been hindered by inaccessibility and, until 
recently, human developmental pharmacology has relied on 
extrapolation from animal studies. Since human placentation 
differs radically from most animal models there is a need 
for a technigue which can readily be applied in humans. 
Furthermore, since our understanding of fetal cardiovascular 
physiology has previously been based on the invasive 
techniques discussed in chapter 2, the development of 
Doppler methods has provided a safe and repeatable method of 
studying fetal cardiovascular physiology in continuing 
pregnancies.
Recent advances in instrumentation now permit detailed 
study of vessels within the fetus as well as the umbilical 
artery and afford opportunities for the safe study of drug 
induced changes within the fetal cardiovascular system.
Interest in the use of Doppler in human developmental 
pharmacology has thus far been directed at the aorta, 
intra-abdominal part of the umbilical vein and the umbilical 
artery and whilst the studies described here are limited to 
the umbilical and uteroplacental arteries the potential 
effects of drugs on other vessels must also be considered.
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Fetal Aorta 
Antihypertens ives
The linear nature of the fetal aorta and its easy
visualisation make it suitable for both quantitative and 
qualitative assessment of blood flow. Montan et al (1987)
have recently reported their findings in 14 patients with
pregnancy induced hypertension who received either 50 or 
lOOmgs of the selective beta blocker, atenolol. This drug is 
of interest since, in the compromised sheep fetus beta 
blockers have been associated with hypoxia. Patients were 
studied before treatment and after one and three days. The 
mean volume flow of 224mls/minute before treatment was no 
different from the mean values of 238 and 227 mls/minute 
obtained after treatment. Interestingly, a significant 
increase in the pulsatility index in the aorta was seen
after atenolol which, it was suggested, was an adverse 
effect, which may represent a redistribution of fetal blood 
flow secondary to changes in peripheral resistance. However, 
since each patient acted as her own control interpretation 
of the study is difficult although it does demonstrate the 
feasibility of using Doppler ultrasound as a tool in the 
evaluation of antihypertensives in pregnancy.
Analgesia
Lindblad, Bernow & Marsal (1987) studied the effect of 
different methods of analgesia on fetal aortic velocities in 
labour. A reduction in velocities was seen following 
pethidine but not after epidural anaesthesia when an 
increase similar to the physiological changes seen in labour 
was observed.
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Newer, more controversial therapies have also been 
evaluated using Doppler velocimetry. Nicolaides et al (1987) 
have shown an increase in aortic blood velocity associated 
with the administration of oxygen by face mask to the 
mothers of severely growth retarded fetuses. It is tempting 
to speculate that this finding reflects improved tissue 
perfusion but it awaits confirmation in larger controlled 
studies.
In addition to studying possible therapies, Doppler 
ultrasound has been used to investigate the effect of 
cigarette smoking. Eriksen & Marsal (1987) have shown a 
transient increase in fetal central circulation following 
the smoking of one cigarette and have suggested that this 
effect is dose related to nicotine content.
Umbilical Vein
Like the aorta, the intra-abdominal part of the 
umbilical vein is suitable for volume studies. Jouppila et 
al (1985a) have investigated the effect of the vasodilator, 
dihydrallazine, on the umbilical circulation. They showed an 
increase in umbilical venous flow, suggesting for the first 
time that this agent can cause dilatation of the umbilical 
vein.
The same group have also shown a correlation between 
levels of 6 keto PGF1 alpha, a metabolite of the potent 
vasodilator prostacyclin, and umbilical venous blood flow. 
In a further report (1985b) of a study to determine if 
exogenous prostacyclin administered intravenously to the 
mother affected umbilical flow no such effect was seen 
despite an increase in maternal levels of metabolites and a
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significant reduction in blood pressure.
Umbilical venous blood flow has also been studied in 
patients receiving beta mimetics (Jouppila et al 1985c) 
which are widely used in the management of premature labour. 
Ritodrine, the most commonly used tocolytic in this class of 
drugs appears to have no effect on umbilical blood flow but 
as the fetal levels are only 2 to 3 percent of maternal 
concentrations this finding is not too surprising. Absence 
of an adverse effect is nevertheless re-assuring.
Umbilical Artery
Although qualitative assessment of the umbilical artery 
waveform can be made using relatively inexpensive equipment 
and this has been the most extensively studied vessel, data 
on drug effects are limited. Montan et al (1987) showed no 
difference in waveforms following atenolol when compared to 
pretreatment values. There is however surprisingly little 
information on other antihypertensives and their effects.
The effects of regional anaesthesia on the umbilical 
artery have been studied. Giles, Lah & Trudinger (1987) 
have shown a reduction in the systolic/diastolic ratio 
following epidural administration of bupivicaine and 
suggested that this represented an improvement in perfusion.
A major limitation of these studies and one which will 
be discussed in later chapters is the interpretation of drug 
induced changes in the umbilical artery flow velocity 
waveform. Since drugs are only administered when there is a 
disease process it seems possible that there may be some 
degree of fetal compromise. Thus apparent improvements in 
the umbilical artery waveform pattern, as indicated by a
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lower systolic/diastolic ratio, may not reflect possible 
adverse changes in other parts of the fetal circulation; an 
increase in fetoplacental perfusion, demonstrated by a 
reduction in umbilical artery systolic/diastolic ratios, may 
possibly be associated with a general reduction in visceral 
blood flow and cerebral perfusion may in particular be 
compromised.
However, now that it is possible to study the fetal 
cerebral vasculature with Doppler (Arbeille et al 1987) this 
problem of interpretation may soon be resolved.
From another perspective, the proposal that umbilical 
artery velocimetry will be a useful adjunct in fetal 
assessment must take into account the possibility of drug 
effects on the waveforms; this is similar to the requirement 
for knowledge of drug affects on cardio tocography for 
adequate interpretation of fetal heart rate patterns (Wood & 
Dobbie 1989) .
The uteroplacental circulation 
Antihypertensives
Obstetricians have been traditionally concerned that 
antihypertensive treatment might adversely affect an already 
compromised pregnancy complicated by hypertension. This 
anxiety was supported by the initial radioisotope studies of 
the uteroplacental circulation by by Dixon, Browne & 
Davey (1963) although later work by Lunell et al (1983) and 
Jouppila et al (1985a) using Indium 113 and Xenon 133 
respectively failed to support the view that significant 
changes in uteroplacental blood flow occurred despite
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showing a reduction in blood pressure following intravenous 
dihydrallazine infusion.
Montan et al (1987) did however show an increase in
uteroplacental pulsatility index, which implied an increased 
vascular resistance, in seven patients who received atenolol 
for hypertension in pregnancy.
Beta mimetics
Brar et al (1988) have shown a significant reduction in 
vascular resistance in the uterine vessels which they 
attributed to the use of ritodrine. This observation was
associated with an increase in maternal heart rate and it 
seems likely therefore that volume blood flow to the uterus 
was significantly increased.
Epidural Anaesthesia
The increasing use of conductive anaesthesia in labour
has led to concern that haemodynamic changes associated with 
its use might affect uterine blood flow. The results of
Doppler studies have been conflicting: Giles, Lah &
Trudinger (1987) found that epidural anaesthesia for 
elective caesarean section improved uteroplacental perfusion 
although in a more recent report Long, Price & Spencer 
(1988) found no change in uteroplacental perfusion in the 
absence of maternal hypotension.
It seems likely that the uteroplacental blood supply
remains remarkably resistant to drug induced changes and 
that locally active factors are responsible. The limitations 
of Doppler studies of the uteroplacental vessels have
already been discussed. As previously mentioned the 
technique examines the uteroplacental vessels with the
lowest resistance, essential when using a continuous wave 
system (Hanretty, Whittle & Rubin 1988) . High resistance 
vessels which are diseased and atheromatous may be found in 
PIH and are presumably less capable of responding to 
potential drug induced changes. It is possible therefore 
that important actions of antihypertensive agents will 
relate to alterations in perfusion pressure effects and 
vascular resistance in the non-diseased low resistance 
vessels. Two studies will now be described in the following 
chapters, which investigate the effects of two 
antihypertensive agents, atenolol and nifedipine, on Doppler 
uteroplacental and umbilical artery waveforms.
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Chapter 10 Effect of established therapy with the beta
blocker, atenolol, given for pregnancy induced 
hypertension on umbilical and uteroplacental 
artery flow velocity waveforms.
10.1 Drug therapy of pregnancy induced 
hypertens ion.
10.2 Pharmacology of atenolol.
10.3 Methods.
10.4 Results.
10.5 Discussion.
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Chapter 10
Effect of established therapy with the beta blocker 
atenolol, for pregnancy induced hypertension on 
uteroplacental and umbilical artery flow velocity 
waveforms.
Chapter 10.1 Drug therapy in the management of PIH.
The question of how best to manage pregnancies 
complicated by hypertension generates "strongly held views" 
(Rubin 1986) which are far from dispassionate. They centre 
on the role of antihypertensives in the haemodynamically 
stable woman with pregnancy induced hypertension and are 
based often on personal experience or anecdote. There is 
very little substantial evidence in the literature 
justifying the use of antihypertensive treatment in mild or 
moderate PIH. The available studies have usually only 
compared one agent against another and there have been few 
placebo controlled studies. Nevertheless there are some data 
concerning the outcome of hypertensive pregnancies managed 
without the use of specific antihypertensive medication.
The definitive treatment of PIH is delivery and studies 
have aimed to reduce the need for this intervention without 
compromising maternal or fetal wellbeing. Andersen & Herbert 
(1977) had this intention in their study of 259 cases of 
pre-eclampsia and eclampsia in which all but two received 
phenobarbitol and sixty-five percent magnesium sulphate. The 
uncorrected perinatal mortality rate in their series was 7%.
Whilst these treatments are not antihypertensive, the
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approach is far from being conservative in terms of drug 
administration. Hauth, Cunningham & Whalley (1976) in a 
study of 346 nulliparous hypertensive women used no drug 
therapy, with the exception of iron supplementation. This 
approach, which entailed intensive maternal and fetal 
supervision, produced excellent results with a perinatal 
mortality rate of 9 per thousand which compared favourably 
with that of the then current rate of 29 per thousand in the 
general obstetric population of that centre.
The use of antihypertensives has always been 
controversial because of the theoretical risk of reducing 
uteroplacental perfusion with antihypertensives and many 
obstetricians avoided their use (De Swiet 1985).
Redman et al (1976) attempted to answer the problem by 
comparing two groups of hypertensive pregnant women, one on 
specific antihypertensive treatment and the other receiving 
only standard obstetric care. In this study those receiving 
methyldopa, which was the antihypertensive used, had an 
improved outcome compared with the untreated cases.
The study, whilst leading the way in assessing 
antihypertensives in pregnancy was in retrospect, seriously 
flawed. The entry criteria did not allow classification into 
pregnancy induced or chronic hypertension and the outcome 
was not known for all patients recruited into the study. 
Most importantly, the obstetric management was determined by 
obstetricians who were aware of those patients receiving 
drug treatment. This does not, however, exclude a beneficial 
effect of treatment since the better outcome in the treated 
group was a result of fewer mid trimester abortions and not
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of a reduction in the number of women developing 
pre-eclampsia.
Leather et al (1967) had also used methyldopa but in 
combination with bendrofluazide in a randomised open trial. 
Though they showed some benefit, interpretation of their 
data is limited by the sub group analyses which were 
performed (Fletcher & Bulpitt 1988) .
The conclusions and recommendations by these authors
were valuable and justifiable but unfortunately these 
studies lacked a placebo control group. Nevertheless the
lack of adverse effect was reassuring and coupled with the
apparent improvement in outcome prompted further studies 
comparing methyldopa with newer therapies.
In a small pilot study Lamming & Symonds (1979) showed 
better blood pressure control with labetolol when compared 
with methyldopa and showed it also to be of value in the
acute situation and this has also been shown by Walker,
Greer & Calder (1983) when comparing this drug with
hydralazine which is the accepted therapy under these 
circumstances. The role of therapy in the management of 
acute severe hypertension will be discussed further in 
chapter 11.
Other beta blockers have been compared with methyldopa 
and Gallery et al (1979) showed a better outcome in terms of 
birth weight in oxprenolol treated babies compared with 
methyldopa but the inclusion criteria invalidated any
attempt to classify the type of hypertension being treated. 
The 'improvement' in birth weight in the oxprenolol patients 
might also be explained by the relatively low birth weight
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in the methyldopa group which was not a finding in other 
studies and for which the explanation remains unclear.
Fidler et al (1983) in a similar study using identical 
entry criteria showed no advantage of beta blockade over 
methyldopa which remains the drug of first choice of therapy 
(de Swiet 1985) because of the reassurance given by 
prolonged paediatric follow up. Nevertheless these studies 
did enlarge upon the evidence supporting the use of beta 
blockade in pregnancy which hitherto had been characterised 
by poorly controlled studies.
Furthermore, the lack of careful definition and 
classification of hypertensive disease in these studies 
limits their relevance and interpretation. Studies of newer 
therapies are required although unfortunately there is a 
lack of adequately controlled studies. Thus Sibai et al 
(1987), comparing the effect of labetolol with 
hospitalisation against hospitalisation alone for the 
treatment of early onset pre-eclampsia found a higher 
incidence of small-for-dates fetuses, coupled with a 
reduction in platelet count in the labetolol group. These 
data conflicted with the results obtained by Walker et al 
(1982) who, in a similar open study showed no adverse 
maternal or fetal effect and suggested a beneficial effect 
related to a reduction in platelet aggregation posssibly 
secondary to a promotion of prostacyclin production.
A more recent study (Plouin et al 1988) compared 
labetolol and methyldopa with inclusion criteria similar to 
those of Fidler et al and Gallery et al but with the 
objective of determining whether differing cardiorespiratory
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effects on the fetus and newborn were produced. They found 
no differences between groups.
In summary, it is difficult to draw conclusions from 
these studies because of the poor definition of the 
hypertensive groups studied, the lack of adequate study 
designs, the various drugs used and a non-uniformity of 
outcome parameters. Nevertheless all of these studies have 
shown that antihypertensive therapy is effective in reducing 
blood pressure in pregnancies complicated by hypertension. 
However, the issue of adverse effects cannot be resolved 
without adequate placebo controlled trials and there are 
only three such studies which have been of sufficient power 
to show a benefit of treatment to the fetus.
Rubin et al (1983a) performed the first of these studies 
to determine if atenolol, a beta 1 selective blocker, was of 
value in improving the maternal and fetal outcome in 
pregnancy induced hypertension. Since the routine approach 
in managing such patients in their centre was 
non-pharmacological this justified a placebo controlled 
trial. One hundred and twenty patients who met the following 
criteria were studied:- systolic blood pressure between 140 
and 170 mmHg or diastolic blood pressure between 90 and 
HOmmHg on two occasions 24 hours apart during the third 
trimester in women with previously uncomplicated 
pregnancies. Data were complete for 39 women in the placebo 
group and 46 in the atenolol group. Data were analysed where 
appropriate on an intention to treat basis.
Proteinuria developed in fewer atenolol treated cases 
(3) than controls (10). All cases of respiratory distress
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syndrome occurred in placebo treated cases. Atenolol treated 
mothers were less likely to be re-admitted to hospital 
before the onset of labour. Babies in the atenolol group had 
lower heart rates but this was not associated with any other 
adverse effect.
In a subsequent report (Rubin et al 1984) the obstetric 
aspects of the use of atenolol were examined. The effect of 
treatment on uric acid, platelet count, urinary oestriol and 
human placental lactogen were assessed since changes in 
laboratory indices of disease progression could alter 
management. Antepartum cardiotocography was also 
investigated.
Only human placental lactogen was significantly 
different, being lower in the treated compared with control 
cases and the explanation was unclear. The authors concluded 
that, given the weight of evidence in support of beneficial 
outcome with atenolol that this finding was not relevant as 
an indicator of fetal compromise. However, the
interpretation, clinically, of drug induced changes in 
biochemical, or biophysical, parameters used in the
assessment of fetal wellbeing is of obvious importance to 
clinical practice.
Many claims have been made for labetolol and advantages 
it may have over atenolol in improving outcome (Walker et al 
1982) but only one study has investigated its use in a
randomised placebo controlled double blind study. Pickles, 
Symonds & Broughton-Pipkin (1989) in their study of 70 
treated and 74 control cases concluded that labetolol may 
have possible advantages over non-pharmacological treatment.
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This interpretation might be a little over optimistic since 
there were no significant differences in fetal outcome 
between the treated and untreated cases. There were twice 
the number of babies born below the tenth centile in the 
labetolol group (10) compared with controls but this did not 
reach statistical significance and was attributed to the 
chance recruitment of babies who were already small to the 
treatment group. The same ratio, 2 to 1, was seen in cases 
of jaundice although in this case with the lesser number in 
the labetolol group. This was interpreted as showing a 
biological advantage of treatment.
Wichman et al (1984) in their study of metoprolol versus 
placebo demonstrated no difference in fetal outcome between 
groups. They did show, however, a higher incidence of 
bradycardia in treated infants.
There was no difference in the overall incidence of 
proteinuric preeclampsia, 6 of 26 women in each group being 
defined as such.
On average, treated babies were 262g lighter than 
controls and most studies of drug treatment versus non-drug 
treatment have shown lower mean bith weights in treated 
cases.
Fletcher and Bulpitt (1988) have suggested that this may 
reflect either a treatment specific effect on fetal growth 
or improved survival in the treated cases born at an earlier 
gestational age. Whilst these authors state that their 
review leads them to believe that there is a clear case for 
antihypertensive treatment in pregnancies complicated by 
hypertension they also conclude by mentioning that adverse
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effects of treatments must be considered and that these may 
only be detectable in large trials.
An important finding in two of these three studies has 
been of smaller babies in treated cases compared with 
controls. Consequently, although the original study by Rubin 
et al was re-assuring, further studies must be performed.
Doppler velocimetry can now be used to study potential 
adverse effects of treatment on fetoplacental and 
uteroplacental blood flow. Furthermore, since it has been 
suggested that Doppler velocimetry may be of value in 
assessing high risk pregnancy (Trudinger et al 1987b) the 
effects of drugs on Doppler waveforms must be known for the 
proper use of this technique as a method of assessing fetal 
wellbeing.
Chapter 10.2 The pharmacology of atenolol.
Atenolol is a hydrophilic selective Beta 1 
adrenoreceptor blocker which has been widely and 
successfully used in non-obstetric hypertension. It is 
rapidly absorbed orally and maximum concentrations are 
reached within 2 to 4 hours. The elimination half life is 
between 6 and 9 hours in non-pregnant subjects (Johnsson & 
Regardh 1976).
Transplacental passage of atenolol was further confirmed 
by Melander et al (1978). who calculated a maternal/fetal 
serum concentration ratio of 1.13 suggesting that during 
steady state conditions blood levels were similar in mother 
and fetus. In one patient who withdrew from their study 24 
hours before delivery there was no detectable atenolol in
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maternal or fetal serum suggesting rapid clearance and lack 
of accumulation in the fetal circulation.
The remainder of this chapter describes a study to 
determine the effect of atenolol on uteroplacental and 
umbilical artery Doppler flow velocity waveforms in patients 
who had been established on atenolol treatment for PIH and 
were presumed to be in a pharmacologically steady state.
Chapter 10.3 Methods.
The effect of atenolol on uteroplacental and umbilical 
artery flow velocity waveforms was studied in ten patients 
treated with 50 or lOOmg given orally for pregnancy induced 
hypertension
Eight patients were studied before treatment and after 
treatment had been established for between 6 and 7 days. A 
further 2 women were studied after treatment was 
established. In all cases the gestation was reliably known 
from menstrual dates and ultrasound examination in the first 
trimester. All patients met the criteria for diagnosis of 
pregnancy induced hypertension mentioned in chapter 3.
The maternal pulse, fetal heart rate, uteroplacental and 
umbilical artery flow velocity waveforms were obtained as 
previously described. Blood pressure was measured using an 
automatic sphygmomanometer. The pulsatility index and 
resistance index were measured in both circulations 
following at least 20 minutes rest in the semi-recumbent 
position.
The same measurements were repeated after treatment was 
established. There was no deterioration in the clinical
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state of any of the cases studied over the treatment period.
Comparisons were made between measurements obtained 
before and after treatment. The results from these ten 
patients were also compared with those obtained from ten 
women who also met the inclusion criteria for the study but 
who, because of variations in the practice of treating 
PIH within the hospital, did not receive drug treatment. 
Though this method of recruitment is clearly not random 
these patients have been selected as untreated controls and 
were matched for maternal and gestational age. There was no 
difference in the disease severity between the untreated 
group and treated groups at the time of recruitment.
Chapter 10.4 Results.
The mean maternal age was 27.4 (5.5) years for the
treated group and 26.2 (4.8) in the untreated cases (p>0.5) 
The gestation at recruitment was 33.1 (2.2) weeks in the
atenolol group. The gestation at study following 
establishment of treatment was 34.0 (1.8) weeks and was the 
same in the untreated cases (34.0 (2.1) weeks).
The effects of treatment: Indices before and after
atenolol.
Figures 10.1-10.7 illustrate the changes following 
treatment in the parameters studied. There were 
statistically significant reductions in systolic and 
diastolic blood pressure (p<0.02) but there was no apparent 
effect on uteroplacental or umbilical artery Doppler 
indices. There was a mean reduction in fetal heart rate of 
7*4 (11.3) beats per minute which did not reach statistical
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significance.
Effects of treatment: comparison with controls.
Figures 10.8-10.14 show comparisons between the 
variables for the ten treated and untreated cases. There was 
no difference in Doppler indices between groups although 
fetal heart rates were lower in the atenolol treated group 
(138 (8.6)bpm versus 146 (6.7)bpm: p=0.032).
For the reasons discussed in chapter 7 it was thought 
prudent to correct for fetal heart rate in comparing the 
treated and untreated cases by converting the resistance 
index to systolic/diastolic ratio and then using the formula 
of Mires et al. as described in chapter 7. Although there 
was no significant difference in heart rate before and after 
treatment in the atenolol group this analysis was also 
performed. The mean corrected systolic/diastolic ratio 
before treatment, 3.91 (2.5), was not significantly
different from the value of 3.12 (1.1) obtained after
treatment ( p> 0.38).
Similarly, this last value was not different from the 
corrected systolic/diastolic ratio in the untreated cases of 
3.85 (2.5) .
Although there was no change overall in Doppler indices 
before and after treatment, one patient had absent end 
diastolic flow, a finding which has been associated with a 
poor fetal or neonatal prognosis (Woo, Liang & Lo 1987; 
Hsieh et al 1988). Absent end diastolic velocity was 
detected immediately before starting atenolol treatment and 
3 resistance index value of 1.0 obtained. The patient was a 
twenty-nine year old primigravida who required treatment for
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PIH at 29 weeks gestation. Doppler studies were repeated on 
the 6th day of treatment when flow throughout the cardiac 
cycle was observed; the resistance index was 0.77 (see 
figure 10.4). Despite the return of normal diastolic flow 
velocities the clinical condition continued to deteriorate , 
something which has not previously been described (Hanretty, 
Whittle & Rubin 1988c). Delivery became necessary in the 
fetal interest after 2 weeks of treatment although the 
waveform remained entirely normal until delivery.
This observation raises the possibility that, in cases 
in which blood flow distribution is already altered, 
treatment may apparently produce a result which masks the 
underlying problem.
Nevertheless, the lack of any overall effect of 
treatment on umbilical artery waveform indices is very 
reassuring and suggests that no major adaptive mechanisms 
are influenced by treatment with atenolol. The lack of any 
effect on maternal waveform indices suggests that diastolic 
flow in the normally adapted spiral arteries are not 
influenced by reductions in blood pressure.
Chapter 10.5 Discussion.
This study, which was open and comparative, was designed 
to evaluate the effects of an antihypertensive medication on 
Doppler flow velocity waveforms. It failed to show any 
difference between treated and untreated cases. This 
suggests that there is no alteration in fetal and 
uteroplacental haemodynamics following treatment 
with atenolol. Possibly in the already compromised fetus
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some change might occur. This possibility reguires further 
study. Interpretation of the study reported here is
obviously limited by its open nature and the non-random
prospective allocation of patients. The lack of a uniform
approach to the pharmacological treatment of pregnancy 
induced hypertension in the unit did however permit a form 
of 'random' allocation insofar as patients were assigned 
randomly to consultants with different approaches to the 
value of drug treatment.
One other study, that of Montan et al (1987) has 
investigated the effects of atenolol on maternal and fetal 
Doppler waveforms. In their study, increases in the
pulsatility index were described in the uteroplacental
vessels in the 7 cases in which this was studied. In the 8
cases in which the umbilical artery waveform was studied no 
change was seen although there was a significant increase in 
fetal aortic pulsatility index. Interestingly, volume flow 
in the fetal aorta was not altered and the suggestion was
made that the change in gualitative flow represented a
differential vasoconstrictor effect on fetal arterioles 
which was not matched in the umbilical artery. It is not 
clear in the paper if there was any deterioration in the 
clinical condition or disease progression over the study 
period, although some patients were delivered between day 1 
and day 3 of the study.
The cases presented in the current study were clinically 
stable and Doppler indices were no different after treatment 
and similar to those obtained from untreated cases. The 
study by Montan et al lacked any comparative group other
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than the treated cases themselves.
Under the conditions of this study atenolol has no 
effect on Doppler uteroplacental and umbilical artery 
Doppler waveforms. In patients with previously normal 
waveforms changes in such waveforms seen in treated cases 
might be attributable to a deteriorating maternal or fetal 
condition. In patients with abnormal waveforms, who may 
already have some redistribution of fetal blood flow, the 
finding of a normal umbilical artery waveform following the 
onset of treatment should not be considered as necessarily 
indicating fetal wellbeing.
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SYSTOLIC BLOOD PRESSURE
BEFORE AND AFTER TREATMENT
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Figure 10.1 Systolic blood pressure before and after
establishment of therapy with atenolol.
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DIASTOLIC BLOOD PRESSURE
BEFORE AND AFTER TREATMENT
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Figure 10.2 Diastolic blood pressure before cind after
establishment of therapy with atenolol.
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UMBILICAL ARTERY PULSATILITY INDEX
BEFORE AND AFTER TREATMENT
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Figure 10.3 Umbilical artery pulsatility index before and
after establishment of therapy with atenolol.
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UMBILICAL ARTERY RESISTANCE INDEX
BEFORE AND AFTER TREATMENT
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Figure 10.4 Umbilical artery resistance index before
after establishment of therapy with atenolol.
and
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FETAL HEART RATE BEFORE
AND AFTER TREATMENT
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Figure 10.5 Fetal heart rate before and after
establishment of therapy with atenolol.
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UTEROPLACENTAL PULSATILITY INDEX
BEFORE AND AFTER TREATMENT
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Figure 10.6 Uteroplacental pulsatility index before and
after establishment of therapy with atenolol.
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UTEROPLACENTAL RESISTANCE INDEX
BEFORE AND AFTER TREATMENT
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Figure 10.7 Uteroplacental resistance index before and
after establishment of therapy with atenolol.
176
SYSTOLIC BLOOD PRESSURE
200
180 -
&
160-1 •  •
140 -I
120
100
Atenolol group Untreated P.I.H.
Figure 10.8 Systolic blood pressure in treated and
untreated cases of PIH.
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DIASTOLIC BLOOD PRESSURE
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Figure 10.9 Diastolic blood pressure in treated and
untreated cases of PIH.
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Figure 10.10 Umbilical artery pulsatility index in
treated and untreated cases of PIH.
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Figure 10.11 Umbilical artery resistance index in treated
and untreated cases of PIH.
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Figure 10.12 Fetal heart rates in treated and untreated
cases of PIH.
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Figure 10.13 Uteroplacental pulsatility index in
and untreated cases of PIH.
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Figure 10.14 Uteroplacental resistance index in treated
and untreated cases of PIH.
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Chapter 11 Effect of acute therapy with a calcium channel 
blocker, nifedipine, on umbilical and utero­
placental artery flow velocity waveforms in 
pregnancy induced hypertension.
11-1 Introduction.
11-2 Clinical pharmacology of nifedipine.
11-3 Methods and patients.
11-4 Results- 
11.5 Discussion.
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Chapter 11
The acute effects of nifedipine on uteroplacental and 
umbilical artery flow velocity waveforms in severe 
pre-eclampsia.
Chapter 11.1 Introduction.
The management of severe pre-eclampsia, particularly 
when of early onset, remains problematical. The control of 
hypertension in particular remains contentious but there is 
a clear need for effective antihypertensive drugs which can 
be easily administered without adverse effect on mother or 
fetus. A common approach has been to institute single agent 
therapy with atenolol, labetolol or methyldopa and in the 
presence of severe disease to add other more potent 
therapies. Vasodilators such as prazosin have been used 
successfully in combination with both oxprenolol (Lubbe & 
Hodge 1981) and atenolol (Rubin et al 1983b) but the success 
of calcium channel blockers in non-obstetric hypertension 
(Murphy, Scriven & Dollery 1983) has led to considerable 
interest in their use in pre-eclampsia. Nifedipine is the 
most commonly used of these agents has been used as a second 
line agent in severe early onset pre-eclampsia and the 
results are promising (Walters & Redman 1984; Rubin, McCabe 
& Low 1984; Constantine et al 1987). However, the potential 
adverse effects of such therapy are not known and it is 
important to determine whether the uteroplacental or 
umbilical circulations are adversely affected by reduction 
in blood pressure. Furthermore, for reasons discussed 
earlier it is important to determine if an effect of such
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therapy is seen on Doppler waveforms, particularly if
Doppler methods are to be accepted as a method of monitoring 
fetal wellbeing in high risk pregnancy. Although nifedipine 
appears to have no acute effect on uteroplacental blood flow 
(Lindow et al 1988) there are no data concerning effects on 
umbilical blood flow or intermediate effects on
uteroplacental blood flow.
Chapter 11.2 Clinical pharmacology of nifedipine.
The clinical pharmacology of nifedipine has been 
comprehensively reviewed recently (Sorkin, Clissold & 
Brogden 1985) and points of relevance to its use in 
obstetrics will be discussed here. Nifedipine has potent 
coronary and peripheral arterial dilator properties which 
are a result of antagonism of calcium influx through the 
slow channel of the cell membrane. Its hypotensive effects 
appear to be more pronounced in hypertensive individuals 
compared to normotensive volunteers (Pedersen et al 1980).
Ninety percent of orally administered nifedipine is
absorbed, almost all of this being in the small intestine 
and peak plasma levels are reached after 0.5 to 2.2 hours in 
the non-pregnant state (Taburet et al 1983). Some workers 
have described a wider variation among individuals and there 
is no information regarding pharmacokinetics of calcium 
channel blockers in hypertensive human pregnancy. Nifedipine 
is eliminated in the urine and although concentrations have 
been found to be higher in patients with renal disease there 
is no significant reduction in renal plasma flow (Austin, 
Robson & Bailey 1983).
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The effective arterial dilating properties are 
associated with a reduction in peripheral vascular
resistance and an increase in peripheral vascular blood
flow.
Nifedipine reduces uterine tone and has been 
investigated as a potentially useful tocolytic (Ulmsten
1984) In the ewe its tocolytic effects can be achieved with 
only mild haemodynamic effects (Golichowski et al 1985) and 
in the human nifedipine has produced satisfactory tocolysis 
without producing any reduction in blood pressure (Read & 
Wellby 1986) . Its use as an antihypertensive in pregnancy 
has usually been as a second line agent in severe disease 
making interpretation of data difficult. The 
anti-aggregatory effects on platelets make its use in 
pre-eclampsia particularly attractive. Clearly an adverse 
effect on uteroplacental perfusion should be excluded 
insofar as possible before widespread use.
Veille, Bissonette & Hohimer (1986) studied the effect 
of nifedipine on uterine blood flow in the pregnant pygmy 
goat and showed no effect on uterine blood flow. However, 
some animal studies have suggested that calcium channel 
blockers have an adverse effect on uteroplacental perfusion 
and fetal oxygenation.
Doppler velocimetry is a method of studying uterine 
blood flow which remains the only safe and repeatable method 
of measurement and the study presented here examines the 
effects of nifedipine on uteroplacental and umbilical artery 
Doppler waveforms.
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Chapter 11.3 Methods and patients.
Nine proteinuric hypertensive women all of whom had been 
normotensive in early pregnancy were studied. Their mean age 
was 28.0 (5.5) years and all but one were primigravidae. The 
gestation at the time of study was 29.4 (4.4) weeks range
24-35 weeks). Doppler uteroplacental and umbilical artery 
waveforms were obtained after a 30 minutes rest period in 
the semi-recumbent position. The pulsatility index was 
calculated individually for each waveform and the mean then 
recorded. Since there was absent end diastolic flow in the 
umbilical artery in 4 of the cases the resistance index and 
systolic/diastolic ratios were not calculated. Blood 
pressure was measured using an automatic sphygmomanometer. 
Maternal pulse and fetal heart rate were also noted. 
Nifedipine retard 20mg was then given orally and all 
recordings repeated hourly for 8 hours. Differences in the 
parameters studied were analysed using repeated measures 
analysis of variance,with Bonferroni multiple comparisons 
where appropriate.
Chapter 11.4 Results.
Despite a rapid and sustained effect on blood pressure, 
no effect was seen on either fetal or maternal Doppler 
indices (Table 11.1). The reduction in systolic blood 
pressure was significant for the first 5 hours after 
treatment and an effect on diastolic and mean arterial blood 
pressure seen throughout the study period. No effect was 
seen on fetal heart rates although the maternal pulse was 
slower at 8 hours than immediately following treatment. For
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ease of display, Figures 11.1-11.5 show the means and 
standard errors for the maternal and fetal variables 
recorded. Although the principal analysis was by 
non-parametric repeated measures analysis of variance, these 
figures also show statistically significant changes detected 
by paired t testing of post treatment to pre-treatment
values.
All patients complained of headache over the first three 
hours of study but this was never severe and reguired no 
treatment.
There were two perinatal deaths. Both followed the
development of fulminant pre-eclampsia at 24 weeks. In both 
cases the fetal condition was poor before treatment; there 
was marked oligohydramnios and absence of any fetal 
movement. Although nifedipine allowed the continuation of 
the pregnancies for 2 and 3 days respectively, deteriorating 
maternal thrombocytopenia necessitated delivery, which was 
achieved vaginally following extra-amniotic prostaglandin
infusion. Of the remaining cases all but one showed evidence 
of intra-uterine growth retardation and all but one were 
delivered by caesarean section. Only two of these babies
were delivered after 37 weeks gestation. In the other cases 
delivery was indicated because of deteriorating maternal 
condition. All these babies have subsequently done well.
Chapter 11.5 Discussion.
The efficacy of calcium channel blockers in controlling 
blood pressure following oral administration makes their use 
attractive in severe PIH. However, since experience with
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nifedipine has largely been based on its value as a second 
line agent in pregnancies which are already severely
compromised, assessment of possible adverse effects is
difficult as the outcome in these pregnancies will often be 
poor. The high risk nature of the cases presented in this 
study was also associated with a high perinatal loss rate 
and although the need for preterm delivery was by no means 
eliminated the blood pressure control obtained suggests that 
nifedipine is an effective first line agent in severe
pre-eclampsia. Since this study lacks a control group, 
witholding treatment in this high risk group being ethically 
unacceptable, our data must be interpreted with caution. 
Nevertheless, the blood pressure control obtained in our 
patients was similar to that reported by Walters & Redman 
(1984) in 8 patients who were also treated with nifedipine 
alone. Their series also showed a trend towards a reduction 
in maternal heart rate at 8 hours but the significance of 
this observation is unclear.
A decrease in uteroplacental blood flow and an increase 
in maternal heart rate have been described in both the
rabbit (Lirette, Holbrook & Katz 1987) and sheep (Harake et 
al 1987) when calcium channel blockers have been given 
intravenously in the study of experimentally induced preterm 
labour. Lirette et al have suggested that this observation 
may be related to massive peripheral vasodilatation and 
diversion of blood to other organs. In contrast with this 
finding is that by Ahokas et al (1988) who studied the 
effects of nifedipine on uteroplacental perfusion in the 
spontaneously hypertensive rat at term. These workers
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demonstrated a 25% drop in mean arterial blood pressure but, 
despite this significant reduction, there was no change in 
uteroplacental perfusion. The animal model used is more 
appropriate to the evaluation of drug effects in essential 
hypertension rather than pre-eclampsia (Ahokas et al 1987) 
but this finding and those presented here do not suggest a 
major change in uteroplacental perfusion.
Fetal hypoxia has also been described following
nicardipine but the results obtained in this study suggest 
that the fetoplacental circulation remains stable following 
nifedipine implying that the fetal condition is unchanged 
although possible changes within the fetus remain
uninvestigated.
These findings support a recent controlled study by
Lindow et al (1988) who studied acute effects of nifedipine 
on uteroplacental blood flow using radioisotope techniques 
and showed no effect on perfusion despite a reduction in 
blood pressure. Although nifedipine crosses the placenta no 
effect was seen on umbilical artery blood flow velocity
waveform.
In conclusion, the data from this small series suggest 
that the use of drugs like nifedipine in severe 
pre-eclampsia may be appropriate. These findings also 
confirm the findings of more invasive studies of the use of 
nifedipine which suggest that uteroplacental blood flow is 
not altered thus confirming the usefulness of Doppler as a 
non-invasive method of assessing drug effects in pregnancy.
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Table 11.1 Maternal and fetal indices following oral 
nifedipine.
Time I(Hrs) 0 1 2 3 4
SBP 157 (18) 142 (9) 141 (13) 143 (9) 148 (14)
DBP 99 (9) 85(5) 84 (6) 84 (7) 85 (7)
PULSE 78 (12) 81 (18) 82 (17) 79 (16) 79 (16)
FUR 143 (7) 145 (11) 142 (10) 143 (9) 140 (10)
UMB PI 1.73 (0.61) 1.85 (0.73) 1.90 (0. 57) 1.81 (0.55) 1.86 (0.
UTH PI 1.20 (0.60) 1.24 (0.80) 1.22 (0. 85) 1.41 (1.05) 1.35 (1.
T ime 5 6 7 8 Significance
SBP 146 (14) 146 (9) 154 (19) 153 (13) p=0.022
DBP 86 (7) 89 (9) 91 (11) 90 (10) P<0.001
PULSE 75 (12) 72 (12) 73 (15) 70 (16) p-0.01 3
FUR 142 (11) 140 (7) 141 (9) 139 (7) p-0.878
UMB PI 1.8 7 (0.50) 1.73 (0.49) 1.82 (0.48) 1.78 (0. 45) p- 0 .848
UTH PI 1.31 (0.88) 1.26 (0.80) 1.22 (0.83) 1.20 (0. 84) p=0.871
F'iqures in parenthesis are standard deviations 
SBP Systol ic blood pressure*
DBP Diastolic blood pressure 
PIIR Fetal heart rate
UMB p] Umbilical artery pulsat ility index
UTR pi uteroplacental pulsatility index
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Figure 11.1 Blood pressure changes after oral nifedipine.
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Figure 11.2 Maternal pulse after oral nifedipine.
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Figure 11.3 Fetal heart rates following oral nifedipine.
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Figure 11.4 Umbilical artery pulsatility index following 
oral nifedipine.
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Figure 11.5 Uteroplacental pulsatility index following 
oral nifedipine.
Chapter 12 Conclusions.
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Chapter 12 Conclusions.
The potential role of Doppler velocimetry in obstetrics 
necessitates an understanding of the determinants of such 
waveforms. In this chapter the factors studied in this 
thesis and their effects on uteroplacental and umbilical 
artery waveforms are discussed.
Determinants of uteroplacental flow velocity waveforms.
The studies described in this thesis permit the 
following conclusions about determinants of uteroplacental 
waveforms to be drawn:
a) In contrast with the only published controlled study of 
uteroplacental waveforms, PIH is associated with Doppler 
patterns of higher resistance than control cases (Chapter 
5). There was no association between the levels of 
hypertension observed and Doppler indices. The clinical 
value of this observation may be limited by the overlap 
between normal and abnormal cases but the observation 
confirms the value of Doppler methods in assessing the 
pathophysiology of the disease.
b) Uteroplacental waveforms were not different from 
controls in pregnancies associated with smal1-for-dates 
fetuses (Chapter 6). This suggests that the vascular 
pathology which results in some cases of growth retardation 
is not sufficiently profound to influence waveforms and that 
Doppler uteroplacental waveform analysis will not aid the 
identification of the smal 1-f or-dates fetus.
c) Despite the high rate of complications in patients with 
elevated maternal serum alphafetoprotein, no difference in
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uteroplacental waveforms was seen in these patients compared 
with controls (Chapter 8). It was not possible therefore to 
identify, using Doppler, a placental vascular lesion which 
might be associated with high risk for certain later 
complications. This finding contrasts with earlier 
uncontrolled studies.
d) The effect of lowering blood pressure using two 
agents with different modes of action was investigated. 
Although both drugs reduced blood pressure significantly 
this had no effect on uteroplacental waveforms (Chapters 
10 & 11) .
Atenolol had no effect on uteroplacental waveforms when 
given orally for one week. Against the background of concern 
for possible effects of antihypertensive medication in 
reducing placental perfusion this is a reassuring finding. 
This is particularly so since, from the results of the study 
described in chapter 5, there is a pre-existing increase in 
resistance to flow in the uteroplacental circulation.
Acute reduction in blood pressure achieved with a 
calcium channel blocker, nifedipine, did not alter 
waveforms. The use of this agent has hitherto been limited 
to high risk pregnancies often with an inevitably poor 
prognosis. The lack of any change in uteroplacental vascular 
resistance, as detected by Doppler, is also reassuring.
Determinants of umbilical artery flow velocity waveforms.
a) In a controlled study of the effect of PIH on umbilical 
artery waveforms no effect was seen overall contrasting with 
the results of uteroplacental waveform changes (Chapter 5) .
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In the sub-group of patients with significant proteinuria 
there was significantly increased resistance to flow. This 
finding suggests that alterations in vascular resistance on 
the fetal side of the placental circulation are secondary to 
those on the maternal side.
b) In contrast, in the study of fetuses which were 
smal1-for-dates, waveforms were obtained showing increased 
resistance to flow compared with controls despite no 
detectable difference in uteroplacental waveforms. This 
suggests that the placental vascular pathology in the 
pregnancies occurred despite apparently normal 
uteroplacental perfusion (Chapter 6).
c) The hypothesis that umbilical artery Doppler waveforms 
would be altered by intravascular transfusion was tested and 
the results obtained were surprising; instead of showing 
increased resistance to flow as might be expected from the 
increase in blood viscosity, a reduction was seen (Chapter 
7). Since this was also seen following cordocentesis it 
seems likely that another mechanism, situated within the 
vessel wall was operative in these cases. Consequently the 
primary hypothesis was not tested but information was 
obtained which indicates the need for further study of the 
effects of cordocentesis on fetal physiology.
d) As with the uteroplacental waveforms, the finding of 
elevated maternal serum alphafetoprotein did not influence 
umbilical artery waveforms despite a higher incidence of 
later complications in this group (Chapter 8).
e) Although atenolol has been shown to cross the placenta 
and has effects on the fetal cardiovasculature, it does not
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influence umbilical artery waveforms. Similarly nifedipine, 
despite having significant effects on reducing maternal 
blood pressure, did not influence umbilical artery 
waveforms (Chapters 10 & 11) .
In summary the studies described in this thesis have 
identified a number of determinants of changes in Doppler 
waveforms in the uteroplacental and umbilical circulation. 
These findings must be considered in interpreting the 
results of further studies directed at determining the 
clinical value of Doppler velocimetry in obstetric practice.
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